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ABSTRACT
The incidence of pertussis, a vaccine-preventable disease that can have severe
complications in infants, has been increasing in the United States over the past three
decades. Vaccine hesitancy and refusal have also increased and are associated with
vaccination exemptions, which in turn are associated with outbreaks of vaccinepreventable diseases, including pertussis. Understanding attitudes towards vaccinations
and identifying geographic disparities of vaccination exemptions and pertussis risks is
useful for guiding control programs. Therefore, the objectives of this study were to: (i)
investigate attitudes towards vaccinations; (ii) identify county-level geographic
disparities and sociodemographic predictors of vaccination exemptions in Florida; (iii)
investigate county-level geographic disparities, temporal changes, and sociodemographic
predictors of pertussis risk in Florida between 2010 and 2018.

Qualitative methods were used to investigate attitudes towards vaccinations in the
Knoxville area of Tennessee. Spatial patterns of vaccination exemption and pertussis
risks were identified using county-level choropleth maps. Tango’s spatial scan statistics
were used to identify clusters of pertussis risk, which were displayed in maps. Negative
binomial and ordinary least squares regression models were used to investigate predictors
of vaccination exemption and pertussis risks, respectively.

Risk perception as well as family and social group attitudes were the primary contributors
to vaccination hesitancy. High vaccination exemption risks were observed in Western and
iv

Central Panhandle, Northeastern, Central-eastern, Central-western, and South-western
coastal counties of Florida. High risks of total vaccination exemptions were observed in
counties with high densities of primary care providers, high median income, high
percentage of Hispanic population, and high percentage of population with college
education. High risks of non-medical exemptions tended to occur in counties with high
percentage of white population. Clusters of high pertussis risks were identified in
Western Panhandle, Northeastern coast, and along the Western coast. Significant
predictors of high county-level pertussis risks were rurality, high median income, and
high percentage of females.

The identified drivers of vaccination hesitancy as well as disparities in and predictors of
vaccination exemptions and pertussis risks are invaluable in guiding evidence-based
health planning, resource allocation, and policy decisions aimed at reducing the burden
and disparities in pertussis risk.
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CHAPTER 1
INTRODUCTION

1

Pertussis, or whooping cough, is a vaccine-preventable disease that remains a major
health concern for infants across the globe. Globally, an estimated 24.1 million people
experience pertussis illness and 160,700 children under five years die annually (Centers
for Disease Control and Prevention (CDC), 2021; World Health Organization (WHO),
2021). Despite being preventable through vaccination, pertussis remains one of the
leading causes of preventable deaths across the globe, as most deaths occur in infants
who have not been vaccinated or are under-vaccinated.

The primary risk factor for pertussis is not being vaccinated. Vaccination exemptions,
refusals, and hesitancy are critical barriers to improving vaccination coverage and
reducing the burden of the disease. Since non-medical exemptions (such as philosophical
or religious exemptions) are associated with vaccination hesitancy and refusal,
investigation of the factors that contribute to these choices or attitudes is needed to
reduce/eliminate local pockets of low vaccination coverage. In addition, investigation of
the socioeconomic and demographic predictors of pertussis risk is necessary to help
understand the epidemiology of the disease. Utilizing qualitative and quantitative
analyses with geographic information system (GIS) technology provides the opportunity
to assess attitudes towards vaccination as well as identify geographic disparities and
predictors of vaccination exemptions and pertussis risk. The information obtained from
such investigations would provide a robust understanding of local pertussis epidemiology
that is important in guiding local public health planning and service provision.
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The objectives of this project were to: (i) qualitatively investigate general vaccination
attitudes and behaviors with specific focus on pertussis vaccination (Chapter 3); (ii)
identify geographic disparities in prevalence of vaccination exemptions and
socioeconomic and demographic predictors of vaccination exemptions among schoolaged children (Chapter 4) (iii) investigate geographic disparities and temporal changes in
pertussis risk at the county level (Chapter 5). Qualitative investigation of vaccination
attitudes was conducted in East Tennessee and quantitative investigation of disparities
and predictors of vaccination exemptions and pertussis risk at the county level were
conducted in Florida.

This dissertation is divided into six chapters. The first and second chapters include the
introduction and literature review, respectively. Chapters 3, 4, and 5 describe studies
addressing the above three objectives. The findings of chapters 3 and 5 have been
published in peer reviewed journals while those of chapter 4 have been submitted for
publication and are currently under peer review. Finally, Chapter 6 provides a summary
of key findings, conclusions and recommendations for future research.
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CHAPTER 2

LITERATURE REVIEW

4

2.1 Etiology
The causative agent for pertussis is Bordetella pertussis, an aerobic gram-negative
bacteria that produces multiple antigenic products including pertussis toxin (PT),
filamentous hemagglutinin (FHA), agglutinogens, adenylate cyclase, pertactin, and
tracheal cytotoxin, all of which contribute to the clinical features of pertussis (Centers for
Disease Control and Prevention, 2015a). Bordetella pertussis is one of ten distinct
species belonging to the family Alcaligenacae (Kilgore et al., 2016). However, B.
parapertussis and B. holmseii have been identified as causative agents of similar
respiratory infections (Bergfors et al., 1999; Njamkepo et al., 2011; Mooi et al., 2012).
An analysis of nasopharyngeal specimens submitted for polymerase chain reaction (PCR)
analysis in suspected pertussis cases between 2008 and 2010 from nine US states
reported that approximately 14% of the specimens were identified as positive for B.
parapertussis (Cherry & Seaton, 2012). Although human infections with B. parapertussis
have been reported, it appears that it produces less severe illness (Heininger et al., 1994)
and is more often the causative agent of respiratory illness in domestic farm animals,
specifically sheep (Leber, 2014).

2.2 Clinical Signs
The incubation period of pertussis is 7-10 days, with a range of 4-21 days. The clinical
course of the disease is characterized by three phases: the catarrhal, paroxysmal, and
convalescent (Centers for Disease Control and Prevention, 2015a; Kilgore et al., 2016).
The duration of illness varies by the time of each phase of the illness. The catarrhal phase
5

of the disease lasts 1-2 weeks with patients exhibiting symptoms including runny nose,
sneezing, fever, and mild cough that gets progressively severe over the course of the
phase. Paroxysmal coughing episodes followed by vomiting and exhaustion are
characteristic of the second phase of the disease. The paroxysmal coughing episodes can
result in decreased oxygen saturation and cyanosis. Paroxysmal attacks often increase in
frequency for 1-2 weeks, stabilize for approximately 2 weeks, and then decrease. Patients
have an average of 15 attacks per day. The final phase, the convalescent phase, lasts
approximately 2-3 weeks wherein the severe cough gradually resolves (Centers for
Disease Control and Prevention, 2015a; Kilgore et al., 2016).

Clinical signs vary by age with the most severe disease occurring in infants (Kilgore et
al., 2016). Adolescents and adults usually experience milder disease; pertussis infections
in adolescents and adults may be asymptomatic or present as a mild cough or cold-like
illness, typically without the characteristic “whooping” cough. Adolescent and adult
populations that are considered to be at high risk for severe illness include: women in
their third trimester of pregnancy, adults with moderate to severe asthma, and
immunocompromised individuals (Centers for Disease Control and Prevention, 2014).
Clinical presentation has also been reported to vary by gender, infecting species (B.
pertussis versus B. parapertussis), infectious dose, and time since last vaccination
(Cherry, 1999; Mattoo & Cherry, 2005; Cherry & Heininger, 2009; Kilgore et al., 2016;
Heininger, 2018).
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2.2.1 Clinical Complications
The most common complication of pertussis is secondary bacterial pneumonia which is
the cause of most pertussis-related deaths with infants having the highest risk of
developing this outcome. Data from 2000 to 2017 show that pneumonia occurred in
13.2% of reported cases, 18.6% of which were in infants less than six months old
(Centers for Disease Control and Prevention, 2015a). It has been estimated that, in the
United States, approximately half of the infants with pertussis will be hospitalized and 1
in 100 infants will die from the disease. The overall case fatality rate in the United States
is 0.8% in infants less than six months old (Hoey, 2003; Kilgore et al., 2016).

Other complications of pertussis include seizures and encephalopathy, likely secondary to
hypoxia from the paroxysmal coughing episodes. These neurologic complications are
more common in infants. Less serious complications include otitis media, anorexia, and
dehydration. The repeated thoracic and abdominal pressure from paroxysmal episodes
can also result in pneumothorax, nose bleeds, subdural hematomas, hernias, and rectal
prolapse. Adolescent and adult complications include difficulty sleeping, urinary
incontinence, pneumonia, rib fracture, syncope, and weight loss (Centers for Disease
Control and Prevention, 2015a).

2.3 Pathogenesis
Exposure occurs through aerosol transmission from an infected host to a susceptible one.
The attachment phase of pathogenesis begins with the adherence of B. pertussis to the
7

tracheal epithelium and lungs (Kilgore et al., 2016). After initial adherence, the bacteria
multiply locally, causing damage to the respiratory tract. As the bacteria colonize lower
into the respiratory tract and lungs, they produce necrotizing bronchitis and diffuse
alveolar damage (Paddock et al., 2008). In severe cases, these events can lead to
pulmonary hypertension, respiratory failure, and death (Paddock et al., 2008; Kilgore et
al., 2016).

2.4 Diagnosis and Treatment
Diagnosis of pertussis depends on clinical history and laboratory testing. Laboratory tests
include bacterial culture, polymerase chain reaction (PCR), and serological testing.
Bacterial culture is considered the gold standard for diagnosis as it is the most specific
(100%) laboratory test for pertussis, although it has lower sensitivity (12-60%) than PCR
(93.5% specificity, 97.1% sensitivity) (Loeffelholz et al., 1999; Lee et al., 2018). It is
critical that nasopharyngeal specimens are collected as early as possible, as they are more
likely to produce accurate test results less than two weeks after the onset of coughing
symptoms as viable bacteria are available during this time period, after which the
sensitivity decreases and false negative rates increase (Centers for Disease Control and
Prevention, 2015a; Centers for Disease Control and Prevention (CDC), 2019a). A study
comparing sensitivities (Se) and specificities (Sp) of culture, PCR, and serological tests
for pertussis reported that after two weeks of cough onset, both culture and PCR are
markedly less sensitive; cultures were reported to have an estimated sensitivity of 9.7%
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after two weeks of cough onset compared to 93.2% in the first two weeks after onset of
cough while the sensitivity of PCR reduced to 21.4% from 81.7% (Lee et al., 2018).

While bacterial culture is considered the gold standard, PCR is the most commonly used
diagnostic test for pertussis as real-time Polymerase Chain Reaction (RT-PCR) allows for
rapid diagnosis in less than 24 hours (Tatti et al., 2013; Lee et al., 2018) while bacterial
culture requires 7 days. Although PCR is not as specific (93.5%) as culture for pertussis
(100%), it does have higher sensitivity (97.1%). An evaluation of the use of PCR for
diagnosis of pertussis reported a specificity of 98%, a positive predictive value of 95%,
and a negative predictive value of 81% (Lind-brandberg et al., 1998). While limited in
their usefulness for prompt diagnosis, serologic assays are routinely used across the globe
for surveillance and diagnosis for late stage illness (>4 weeks after onset of cough) when
culture and PCR have poor diagnostic utility (May et al., 2012; Vaz-de-Lima et al., 2014;
World Health Organization (WHO), 2018). Serologic tests may be used to diagnose latestage pertussis infections, though there are many barriers to using serology for successful
diagnosis. For examples, past infections and recent (within the past year) vaccination
against pertussis can be detected by serological testing. Due to the limitations of using
serological tests for diagnosis of active pertussis infections, the World Health
Organization (WHO) recommends that serological testing be used for diagnosis of
pertussis only if it has been more than four weeks since onset of coughing (World Health
Organization (WHO), 2018). It also should not be used within a year of pertussis
vaccination as IgG antibodies may persist (World Health Organization (WHO), 2018).
9

There is currently no assay approved by the US Food and Drug Administration (FDA) for
use in the United States. Moreover, results of serological testing are not included in the
pertussis case definition used by the Council of State and Territorial Epidemiologists
(CSTE). However, serological testing may be useful for identification of adolescent and
adult cases that may have low clinical suspicion until the cough has persisted for several
weeks (World Health Organization (WHO), 2018).

2.4.1 Diagnostic Criteria
The WHO clinical case definition of pertussis is, “a case diagnosed as pertussis by a
physician or a person with a cough lasting at least two weeks with one of the following
symptoms: paroxysmal cough, inspiratory whooping, or post-tussive vomiting” (Cherry
et al., 2012). The definition for a laboratory confirmed case of pertussis, on the other
hand, includes isolation of B. pertussis through culture, detection by PCR, or positive
paired serology (World Health Organization (WHO), 2001).

In the United States, the clinical pertussis case definition by the CSTE is “a cough lasting
greater than or equal to two weeks with at least one of the following signs or symptoms
(in the absence of a more likely diagnosis): paroxysms of coughing, inspiratory whoop,
post-tussive vomiting, or apnea (with or without cyanosis)” (Council of State and
Territorial Epidemiologists, 2019). The CSTE laboratory criteria for diagnosis of the
disease also includes isolation of B. pertussis from a clinical specimen through culture or
positive PCR for B. pertussis. The CSTE also presents criteria for a probable case, which
10

include meeting the clinical criteria in absence of a more likely diagnosis or having
epidemiologic linkage through known contact with a laboratory confirmed case and
having a cough of any duration with at least one of the following symptoms: paroxysmal
cough, inspiratory whooping, post-tussive vomiting, or apnea (Council of State and
Territorial Epidemiologists, 2019).

2.4.2 Treatment
Antimicrobial treatment does not lessen the severity of pertussis illness unless it is started
early in the course of infection, specifically prior to the onset of paroxysmal coughing.
Three macrolide antibiotics (azithromycin, erythromycin, and clarithromycin) are
recommended for treatment of pertussis. The most commonly used antibiotic is
azithromycin, because it requires a short (5 day) course of treatment and is preferred
amongst the macrolides for infants younger than one month. Caution is indicated for
macrolide use in infants less than one month old because of its potential association with
infantile hypertrophic pyloric stenosis (IHPS). However, macrolides are still used
because the risk of IHPS in infants is lower than the risk of developing severe
complications from pertussis infection (Centers for Disease Control and Prevention,
2005). Trimethoprim-sulfamethoxazole (TMP-SMZ) is recommended for infants older
than 2 months when macrolides are contraindicated or when antibiotic resistance is
suspected. The Centers for Disease Control and Prevention recommend macrolide
antibiotic chemoprophylaxis for any high risk contacts and household contacts of a
pertussis patient for outbreak control (Sprauer et al., 1992; Centers for Disease Control
11

and Prevention, 2005). B. pertussis resistance to macrolide antibiotics is rare, though
some studies have reported that B. parapertussis is less susceptible to macrolide
antibiotics. Other studies, however, have reported that macrolides (including
azithromycin, erythromycin, clarithromycin), TMP-SMZ, and ciprofloxacin are useful
when treating Bordetella parapertussis infections (Hoppe, Rahimi-Galougahi & Seibert,
1996; Hoppe & Bryskier, 1998; Centers for Disease Control and Prevention, 2005).

2.5 Transmission
Bordetella pertussis has been thought to be transmitted through aerosolized respiratory
droplets but it was not until 2012 that this mode of transmission was documented in a
controlled study in a baboon challenge trial (Schellekens, Von König & Gardner, 2005;
Warfel, Beren & Merkel, 2012). While the mode of transmission has only recently been
confirmed through controlled studies, high transmissibility has been consistently
documented in epidemiologic studies of outbreaks, in households, and in school settings.
Adults and adolescents have been identified as important sources of infection for infants
(Wendelboe et al., 2007; Centers for Disease Control and Prevention, 2015b). An
international prospective study of laboratory confirmed cases reported that parents
accounted for 55% of cases followed by siblings (16%), friends or cousins (10%), and
grandparents (6%) (Wendelboe et al., 2007).

Household transmission studies report attack rates ranging from 58% to 100% (Warfel,
Beren & Merkel, 2012). The Center for Disease Control and Prevention reports that the
12

household attack rate is around 80%, though other studies have reported estimates
ranging from 64% to 86%, with an average of 76% (Mertsola et al., 1983; Stehr et al.,
1998; Warfel, Beren & Merkel, 2012; Centers for Disease Control and Prevention,
2015a). Transmission outside of the household has been reported as lower, though it is
more difficult to quantify. Classroom studies from the United States and Canada have
reported a range of attack rates from 0% to 36% (de Moissac, Ronald & Peppler, 1994;
Brennan et al., 2000; Berger et al., 2010; Warfel, Beren & Merkel, 2012). A similar
classroom study from Estonia reported an attack rate of 36% (Torm et al., 2005).

2.6 Epidemiology
2.6.1 Global Burden
Pertussis is endemic worldwide and epidemics typically occur in 3-5 year cycles (Centers
for Disease Control and Prevention, 2015b). The global burden of pertussis disease and
death is estimated to be upwards of 24 million cases and over 160,000 deaths in children
under 5 years old per year (Yeung et al., 2017; Centers for Disease Control and
Prevention (CDC), 2021). Pertussis incidence and distribution across the world has
significant geographic variability (Gabutti & Rota, 2012; Jackson & Rohani, 2014; Tan et
al., 2015). For example, estimates from the WHO report that Africa has the highest case
counts of the disease, contributing 33% (7.8 million) of the global cases and 58%
(92,500) of global deaths, followed by the southeast Asia which contributes 26% (6.3
million) of the global cases (Yeung et al., 2017). Europe has the lowest estimated cases of
disease globally, contributing 1.6 million cases and 900 deaths annually (Yeung et al.,
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2017). Pertussis incidence data are more often available in western and developed nations
(Crowcroft et al., 2003) and therefore, outbreaks of the disease are frequently reported in
North America and Europe. These outbreaks have been reported in Canada, the United
States, the Netherlands, Finland, and Germany. Surveillance data from Europe indicate a
resurgence of pertussis cases and an increase in the number of outbreaks since the late
1990s (Syed & Bana, 2014).

A review of global pertussis epidemiology between 1990 and 2010 reported that many
nations including Japan, Israel, Australia, Belgium, the Czech Republic, Bulgaria, the
Netherlands, Hungary, and Poland have had significant increases in disease incidence
risks. The range of reported incidence risks in these nations in 2010 was between 0.3
(Hungary) and 153.8 (Australia) cases per 100,000. Other nations have seen significant
decreases in incidence risk, including Vietnam, Thailand, China, Ukraine, Denmark,
Belarus, Spain, the United Kingdom, Greece, Italy, Saudi Arabia, and Canada. The range
of reported incidence in these nations in 2010 was between 0.1 cases per 100,000 in
China and 2.3 cases per 100,000 in Ukraine (Jackson & Rohani, 2014).

Data from Low- and Middle-income countries (LMIC) is often sparse. However, a few
serologic surveillance studies have been conducted. Pertussis cases have decreased
overall in the WHO African region between 2000 and 2013, however, Nigeria reported
the second highest number of cases (11,281) worldwide in 2009 (Tan et al., 2015). A
recent report of findings and recommendations of the Global Pertussis Initiative (GPI)
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highlights the difficulties of understanding the epidemiology of the disease in developing
nations (Muloiwa et al., 2018). In South Africa between 2008 and 2011, 67% of
laboratory confirmed cases were in children less than three months old and as of 2011
had a reported incidence rate of 5.8 per 1,000 child-months (Nunes et al., 2016; Muloiwa
et al., 2018). A hospital study from Niger reported an incidence risk of 8.2 per 1,000
children less than five years old (Jusot et al., 2014). Similar hospital studies have reported
incidence risks of 1.3 per 1,000 population in Ethiopia (Alamaw, Kassa & Gelaw, 2017),
114 per 1,000 population over seven years old in Kenya (Muller, Leeuwenburg &
Voorhoeve, 1984) , and incidence rate of 2.4 cases per 1,000 infant-months in Zambia
(Gill et al., 2016).

A multicenter study in China reported an annual incidence risk of 7,000 per 100,000
population, with age-specific annual incidence risks of 9,100 per 100,000 in children
aged 6-8 years and 14,600 per 100,000 in people aged 12-20 years (Wang & Zhu, 2011).
This shift in risks to older age groups is consistent with trends identified globally (Mooi
et al., 2009; Syed & Bana, 2014). A review of the epidemiology of pertussis in Italy
between 1996 and 2009 also reported increases in incidence risk in adolescents (Gabutti
& Rota, 2012).

2.6.2 Burden in North America
Pertussis incidence risk in Canada as of 2012 was reported as 13.9 per 100,000 (Smith et
al., 2014; Public Health Agency of Canada, 2020). A trend of increasing incidence risk in
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older children and adolescent populations has been reported in Canada as well (Smith et
al., 2014; Thommes et al., 2020). Pertussis incidence risk varies by province, with the
highest risk in 2000 being in British Columbia and Yukon (Smith et al., 2014).

A recent time trend analysis reported that the incidence risk of pertussis in infants less
than one year old in Mexico was approximately 12 per 100,000 infants (Guzman-holst et
al., 2021). A seroprevalence study conducted in Mexico in 2010 reported that 47.4% of
subjects were seropositive for anti-pertussis toxin (anti-PT) antibodies (Conde-Glez et al.,
2013). The same study reported that males and children aged one to nine years old had
the highest seroprevalence, at 53.4% and 59.3%, respectively (Conde-Glez et al., 2013).
Another seroprevalence study of pertussis in adolescents in Mexico City reported the
incidence risk to be 5 per 1,000 students (Sandoval et al., 2008).

2.6.2.1 United States
The incidence of pertussis and number of pertussis epidemics have been increasing in the
United States for the past thirty years. The cause of the changing epidemiology of
pertussis in the US remains unclear, however, it is likely the result of multiple factors,
including rising vaccine hesitancy, the change from a whole-cell vaccine to the currently
used combination Diphtheria and Tetanus toxoids and acellular Pertussis (DTaP) vaccine
as well as non-medical or philosophical vaccination exemptions from vaccination
requirements for school entry (Clark, 2014).
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Infants less than one year old have the highest rates of pertussis in the United States
(Wirsing von Konig et al., 2002). Between 2000 and 2006, infants less than one year old
accounted for 93% of the pertussis-related mortality and had the highest burden of
disease in the country (Tanaka et al., 2003; Vitek et al., 2003; Murphy et al., 2008; Liang
et al., 2018). In 2019, the incidence risk of the disease among infants less than 6 months
old in the United States was 72.3 per 100,000 and 1.4 per 100,000 in adults over 20 years
old (Centers for Disease Control and Prevention (CDC), 2019b). Adolescents accounted
for over 30% of cases in epidemics in 2004 and 2005 in the United States (Clark, 2014).
A review of pertussis in the United States between 2000 and 2016 reported that cases of
pertussis occurred predominantly in white people (88.2%). Ten percent of total cases
were hospitalized and 0.1% of total cases lead to death. Infants had the highest incidence
(75.3 per 100,000) and accounted for 88.8% of deaths. During the study period,
significant increases in risks were reported for all age groups except infants less than one
year old and 19-64 years old, consistent with global trends (Skoff, Hadler & Hariri,
2019).

2.6.2.2 Florida
A review of pertussis epidemiology in Florida between 2000 and 2006 reported an
increase in incidence risk during the study period from 0.44 to 1.28 per 100,000
population (Schulte et al., 2010). Increases in incidence risk has clearly continued as
evidenced by the risk reported in 2019, when the annual incidence risk in children less
than one year old was 38.1 per 100,000 and 3.4 per 100,000 in adolescents aged 12-18
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years. Higher incidence risk of pertussis was reported in central Florida and in the
panhandle. Forty nine percent of cases in 2019 were not fully vaccinated, with 28% never
vaccinated, 14% under vaccinated, and 7% too young to be vaccinated (Florida
Department of Health, 2019). The trend of increasing incidence risk among adolescent
populations was reported during this time as well. Prior to 2001, the most frequently
reported cases were in infants less than one year old, but after 2001, adolescents and
adults were more frequently affected. The proportion of cases in adolescents and adults
increased from 12% to 21% between 2000 and 2006 (Schulte et al., 2010).

2.6.3 Geographic Distribution
Pertussis occurs in all six WHO regions: Africa, the Americas, the Eastern
Mediterranean, Europe, Southeast Asia, and the Western Pacific (Tan et al., 2015).
Between 2003 and 2007, the European Centre for Disease Prevention and Control
(ECDC) reported an overall annual incidence risk of 4.1 per 100,000 population, with the
highest incidence risks being reported in Norway, Sweden, and Finland (Gabutti & Rota,
2012; Jackson & Rohani, 2014). The incidence risk of pertussis in central and eastern
European nations between 1995 and 2005 was reported to be less than 3 per 100,000
population (Gabutti & Rota, 2012). Another analysis of 54 countries between 1990 and
2010 reported significant geographic variability in incidence risk (Jackson & Rohani,
2014).
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Pertussis incidence risk varies greatly at the state or provincial geographic scale, as well.
A recent study of the geographic variability within Iran analyzed data from 2009 to 2015
with the intention of modeling future risk. The authors reported significant increases in
incidence risks that varied by province and identified several provinces with higher than
average risks: Qom, Mazandaran, Tehran, Qazvin, and Zanjan provinces (Moradi &
Azim, 2021). Zanjan, Qazvin, and Qom provinces were also identified as provinces with
significantly higher pertussis risks in a separate cross-sectional study investigating the
spatial and temporal distribution of pertussis in Iran between 2012 and 2018
(Alimohamadi et al., 2020). A recent analysis of the epidemiology of reported pertussis
cases in the United States between 2000 and 2016 reported that the West North Central
(Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota) and
Mountain (Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, and
Wyoming) regions have the highest annual incidence risks at 11.9 and 11.5 per 100,000,
respectively. The regions with the lowest annual incidence risks included the South
Atlantic (Delaware, Washington, D.C., Florida, Georgia, Maryland, North Carolina,
South Carolina, Virginia, and West Virginia) and East South Central (Alabama,
Kentucky, Mississippi, and Tennessee), reporting risks of 2.5 and 3.1 per 100,000,
respectively (Skoff, Hadler & Hariri, 2019).

Geographic variation at the county level was noted in a review of pertussis cases in
Florida between 2000 and 2006, with three counties (Hillsborough, Pinellas, and Duval)
around metropolitan areas (Tampa, St. Petersburg, and Jacksonville, respectively)
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reporting at least 10% of the total cases each. More than half of total cases were reported
in females (53%) and the majority were white non-Hispanic (64%) (Schulte et al., 2010).

2.6.4 Temporal Patterns
Seasonal patterns of pertussis have been inconsistent. A review of worldwide pertussis
epidemiology suggests that pertussis has a summer-fall seasonality (Gabutti & Rota,
2012). A hierarchical time-series analysis of pertussis seasonality and periodicity in the
Netherlands between 1996 and 2006 showed peak incidence in August each year for all
age groups except among adolescents, for whom peaks occurred in November (de Greeff
et al., 2009). Seasonality may vary geographically as the peak incidence has been
reported to occur in February and September in England and Wales while in Germany the
highest incidence was between June and September, similar to Australia (Fine &
Clarkson, 1986; Clarke et al., 2013; Hitz, Tewald & Eggers, 2020).

Pertussis incidence risk has been increasing in the United States, as well as globally, over
the past three decades. An analysis of the reported cases of pertussis in the United States
between 2000 and 2016 revealed a significant increase over time in all age groups except
infants less than one year old and adults aged 19-34 years (Skoff, Hadler & Hariri,
2019). The increase in incidence risk over time occurred in adolescents aged 11-18,
increasing from 6.1 to 26.1 per 100,000 between 2001 and 2004, and children aged 7-10,
increasing from 8.5 to 58.5 per 100,000 (Skoff, Hadler & Hariri, 2019).
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A comparative study of 64 countries reported that pertussis epidemics have a cyclic
pattern every 2-4.6 years, where the magnitude of the cycles varies geographically
(Broutin et al., 2010). An analysis of pertussis transmission dynamics in the United States
between 1938 and 2010 identified that pertussis peaks occur in four year cycles
(Magpantay & Rohani, 2015). Cyclicity does seem to vary by geographic region. Skoff
and colleagues reported that epidemic peak intervals ranged from 2 to 7 years depending
on US region (Skoff, Hadler & Hariri, 2019). In the United States, the average national
incidence risk in non-peak years from 2000 to 2008 was 3.4 per 100,000 and during peak
years between 2009 and 2016 the national average incidence increased to 5.9 per 100,000
(Skoff, Hadler & Hariri, 2019). The overall percent of hospitalizations decreased
significantly from 20.6% in 2000 to 6.7% in 2016. However, hospitalizations increased in
patients 7-10 years old (6.7%), 30-64 (4.7%), and ≥65 year old (2.8%) patients (Skoff,
Hadler & Hariri, 2019).

2.6.5 Risk Factors
Lack of vaccination or delayed vaccination is the primary risk factor for pertussis
infection (Sealey, Belcher & Preston, 2016). Low birth weight, low gestational age of the
infant, and lymphocytosis are risk factors of fatal disease in infants (Wortis et al., 1996;
Murray et al., 2013; Winter et al., 2015; Winter, 2016). An analysis of the US Multiple
Cause-of-Death and Linked Birth/Infant Death databases between 1999 and 2004
reported that birth weight of less than 2500g, female sex, an Apgar score <8 (assessment
of newborn health; score out of possible 10), a mother with <12 years of education, and
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Hispanic ethnicity were associated with high risk of pertussis deaths (Haberling et al.,
2009). An Australian study reported that predictors of hospitalization with pertussis in
infants less than two months old included indigenous ethnicity (RR=1.7, 95% CI=1.032.83), and receiving less than two doses of vaccine (RR=4.1, 95% CI=1.37-12.11)
(Kolos, Menzies & McIntyre, 2007). A prospective study in Africa reported that HIV
exposure or infection, poor nutrition, and maternal B. pertussis infection were associated
with high risk of pertussis in children (Muloiwa et al., 2020). This study also reported
higher risk of pertussis among infants when they had a caregiver with pertussis (Muloiwa
et al., 2020).

Risk of fatal disease in infants is reduced through vaccination, early detection and early
delivery of treatment (Winter et al., 2015). An analysis of hospitalizations in France
reported that having the first dose of vaccine and being seen by a doctor late in the course
of the disease were associated with decreased risk of hospitalization in an intensive care
unit, assisted ventilation, or death (Briand, Bonmarin & Lévy-Bruhl, 2007). Other studies
also report that being under-vaccinated increased risk of hospitalization from pertussis
(Clarke et al., 2013). Risk factors for pertussis hospitalization among adults include high
body mass index (30+ kg/m2) and asthma (Liu et al., 2012).

Female sex has been reported as a risk factor for pertussis (Jenkinson, 1995; De Serres et
al., 2000; Broutin et al., 2004; Paradowska-Stankiewicz & Rudowska, 2015; Huang et al.,
2017; Abu-Raya et al., 2020; Alimohamadi et al., 2020). An analysis of an outbreak of
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pertussis in Quebec, Canada, reported that the main risk factors for pertussis were being
female and working in an educational or healthcare setting (De Serres et al., 2000). The
authors proposed that the higher risk may be the result of higher awareness of pertussis
among females as well as healthcare workers, which could lead them to seek medical
care more readily than men (De Serres et al., 2000). Higher pertussis risk and pertussis
complications among females have also been reported in the United Kingdom and
Canada (Jenkinson, 1995; Abu-Raya et al., 2020). Lower socio-economic status,
particularly living below poverty line, poor access to medical care, no vaccination or
under-vaccination, and female sex have been identified as sociodemographic predictors
of high pertussis risk (De Serres et al., 2000; Klevens MR, 2001; Paddock et al., 2008;
Paradowska-Stankiewicz & Rudowska, 2015). Additionally, higher rates of pertussis
cases, hospitalization, and deaths have been reported among infants of Hispanic ethnicity
compared to other racial and ethnic groups since 1990 in California (Tanaka et al., 2003;
Winter et al., 2012; Winter, 2016).

2.6.6 Reporting
Although pertussis is a reportable disease, it remains markedly under-reported and so the
true burden of morbidity and mortality from pertussis is higher than what is reported to
public health agencies (Tan et al., 2015). Most studies of pertussis incidence and
reemergence are from developed or Western nations and it has been proposed that
records from some countries including China, India, Pakistan, Nigeria, South Africa, and
Indonesia have greatly under-reported pertussis cases (Mooi et al., 2009; Syed & Bana,
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2014; Tan et al., 2015). Differences in health care access, infrastructure, diagnostic tools,
case definitions, and clinical training all contribute to under-reporting (Tan et al., 2015).

One source of under-reporting includes clinicians failing to suspect pertussis when
presented with non-classical presentation or in age groups where infection is not as
severe. For example, a study of under-reporting in the Netherlands reported that 19% of
cases are missed if physicians rely on clinical suspicion alone and recommended that
routine diagnostics should be considered to address this gap (ven den Brink et al., 2014).
Cases in adolescent and adult patients may go undetected and unreported as these patients
often have milder symptoms. Their diagnosis is often delayed or missed because of low
clinical suspicion as well as the lower effectiveness of diagnostic tests in later stages of
illness. Culture and PCR tests have lower sensitivity (culture: 9.7%; PCR:21.4%) later in
the course of the illness (Syed & Bana, 2014; Centers for Disease Control and
Prevention, 2015a). Non-classical clinical presentation as well as asymptomatic
infections have been proposed as sources of under-reporting. It has been suggested that
asymptomatic infection is approximately five times more common than reported (Ward et
al., 2006; Sealey, Belcher & Preston, 2016).

Another source of under-reporting is poor surveillance, although recent collaborations
have worked to improve this. The Integrated Disease Surveillance and Response system
was created and provided to WHO member states in order to improve surveillance but
this point data remains limited in many nations (Lukwago et al., 2013; Tan et al., 2015).
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The Latin American Pertussis Project is a collaborative effort between the Sabin Vaccine
Institute, the Pan American Health Organization (PAHO), the CDC, and the Latin
American Ministries of Health. It has worked to establish access to RT-PCR for case
confirmation to improve diagnostic capabilities so that more robust surveillance systems
may be developed.

2.7 Control and Prevention
The most critical aspect of control and prevention of pertussis is vaccination. The WHO
estimates that approximately 294,000 preventable deaths in children under five occur
worldwide as a result of incomplete vaccination (Forsyth et al., 2007). To address global
vaccination goals, the Global Vaccine Action Plan (GVAP) set goals for pertussis
vaccination coverage during an initiative called “The Decade of Vaccines”. Their goal of
95% global pediatric vaccine series coverage by 2015 was not met and coverage
plateaued at 86% globally as of 2018. Interestingly, the global trends in other critical
childhood vaccinations increased between 2010 and 2018, with pertussis vaccination
being the only one to plateau below the target. The WHO estimates that approximately 20
million infants are not fully immunized. This documented low coverage is worsening in
nations impacted by conflict and socioeconomic crises (World Health Organization
(WHO), 2020).

Other prevention and control strategies for pertussis include hygienic practices (e.g. hand
washing) to prevent the spread through respiratory secretions as well as
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chemoprophylaxis with macrolide antibiotics in known exposed cases. A study of the
effectiveness of chemoprophylaxis with azithromycin in exposed contacts in Spain
between 2012 and 2013 reported that a full course of azithromycin was 43.9% effective
(Alvarez et al., 2020). However, a review of the use of erythromycin as
chemoprophylaxis in the UK reported that there was no evidence of benefit (Dodhia et
al., 2002).

2.7.1 Pertussis Vaccines
There are multiple acellular pertussis vaccines currently available and approved for use in
the United States, including Diphtheria and Tetanus toxoids and acellular Pertussis
(DTaP) vaccine, Tetanus, diphtheria and acellular pertussis (Tdap) vaccine, DTaP with
Hepatitis B and Inactivated Polio Vaccine (DTaP-HepB-IPV) vaccine, DTaP with
Inactivated Polio Vaccine and Haemophilus influenzae type B (DTaP-IPV/Hib) vaccine,
and DTaP-IPV-Hib with Hepatitis B (DTaP-IPV-Hib-HepB) vaccine (Centers for
Disease Control and Prevention, 2015a). These combination vaccines have been
developed with the goal of improving vaccination coverage rates by reducing the number
of injections needed per visit and in total. The different versions of these pediatric
pertussis vaccines are utilized based on availability, patient preference, and provider
assessment (Oliver & Moore, 2020). Acellular pertussis vaccines are the predominant
pertussis vaccines used in North America, Europe, Australia, the Middle East, China,
Japan, and New Zealand (Chitkara et al., 2020). While whole cell pertussis vaccines are
no longer used in the United States due to concerns about adverse side effects,
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Diphtheria-Tetanus-whole cell Pertussis (DTwP, DTP) vaccines are still in use in many
areas across the globe, including South America, parts of Central America, Russia,
Northern Asia, the Middle East, India, South East Asia, Indonesia, and Africa, and are
also regularly combined with Haemophilus influenzae type B (Hib), Hepatitis B (HepB),
and Polio (IPV) (World Health Organization (WHO), 2010; Chitkara et al., 2020).

In the United States, it is recommended that children under the age of seven receive
DTaP vaccines and that persons over the age of seven receive Tetanus-diphtheria (Td) or
Tdap vaccines. Pertussis vaccines are administered through intramuscular injection in
two series: a childhood and an adult “booster” series. The childhood series (DTaP
varieties) are recommended at 2, 4, 6, 15-18 months, and at 4-6 years. Recommendation
for timing of doses is dependent on the type of DTaP vaccine used and previous
vaccination history. A single dose adult vaccination is recommended at age 11-18 and
should continue every ten years unless indicated sooner for tetanus prophylaxis (Centers
for Disease Control and Prevention, 2015a; Havers et al., 2020).

2.7.2 Immunity
An immune response to any of the antigenic, biologically active products of B. pertussis
produces temporary immunity (Centers for Disease Control and Prevention, 2015a;
Kilgore et al., 2016). Estimates of period of immunity from natural infection range from
3.5 to 30 years (Wirsing Von König et al., 1995; Versteegh et al., 2002; Wendelboe et al.,
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2005; Wearing & Rohani, 2009) and 4-7 years for vaccine-induced immunity (Tindberg,
Blennow & Granstrom, 1999; Klein et al., 2012; Kilgore et al., 2016).

Immunity from all pertussis vaccines is provided by a combination of humoral and
cellular immunity (Kapil & Merkel, 2019). The pediatric DTaP and adult Tdap vaccines
in use seem to provide immunity by inducing a Th-2 CD4-positive cellular immune
response, though antibodies are produced through a humoral immune response as well
(Higgins et al., 2006; Kilgore et al., 2016).

2.7.3 Vaccine Efficacy
The DTaP vaccine in children who receive all five doses on schedule protects 98% of
recipients within a year of the most recent dose and approximately 71% of children five
years after their last dose (Centers for Disease Control and Prevention, 2015a). The same
levels of protection against pertussis infection is provided by the combination vaccines
(DTaP-HepB-IPV, DTaP-IPV/Hib, and DTaP-IPV-Hib-HepB) (Commitee on Infectious
Diseases, 1999). Tdap has demonstrated 73% protection in adolescents in the first year
and 34% of people four years after receiving the vaccine (Centers for Disease Control
and Prevention, 2015a).

A systematic review of the safety and efficacy of all pertussis vaccines reported that
whole cell vaccines are more effective than two-component acellular vaccines, less
effective than three component acellular vaccines, and equally effective as five28

component acellular vaccines against mild pertussis. A comparative efficacy trial in
Germany reported that the whole cell DTP provided 93% efficacy compared to the DTaP,
which had a reported 83% efficacy (Stehr et al., 1998; Jefferson, Rudin & DiPietrantonj,
2003).

2.7.4 Pertussis Vaccination for Special Populations
Pertussis vaccinations including the childhood series and booster doses are recommended
for everyone over the age of 2 months (World Health Organization (WHO), 2021).
Recommendations specific to high-risk or special populations include pregnant women
and healthcare workers. The Centers for Disease Control and Prevention (CDC) in
conjunction with the Advisory Committee on Immunization Practices (ACIP)
recommend that pregnant women receive a dose of the adult booster of Tdap during each
pregnancy between gestational weeks 27 and 36. The goal of this recommendation is to
provide maternal pertussis antibodies to the newborn as well as to prevent transmission
from mother to baby during the birth process (Centers for Disease Control and Prevention
(CDC), 2020). It is recommended that healthcare personnel receive a single Tdap dose if
they have not received one previously and they have direct patient contact (Centers for
Disease Control and Prevention (CDC), 2020).

2.7.5 Vaccination Coverage in the United States
The Advisory Committee on Immunization Practices (ACIP) includes pertussis among
the fourteen illnesses they recommend vaccination for by 24 months. There are reports
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of increasing percentage of children that are under-vaccinated and pockets of
susceptibility occurring where protection is much lower than the national estimates (Hill
et al., 2018). Among children born in 2014-2017, 93.3% had received three or more
doses of DTaP by 2017 and 80.6% had received four or more doses by age 24 months, a
0.2% decrease from 2016 (Hill et al., 2020). Pertussis vaccination coverage varies across
the United States. The states with the lowest coverages (84.0-92.6%) in the 2019-2020
school year include: Oregon, Idaho, Utah, Arizona, Kansas, Minnesota, Indiana, Ohio,
New Hampshire, and Alabama (Centers for Disease Control and Prevention, 2020).

While vaccination coverage for pediatric vaccination against pertussis has been declining,
receipt of the adult booster (Tdap) has improved, though overall coverage remains low. A
recent survey of pertussis vaccination receipt in the United States reported that only
31.2% of adults 19 years and older had received a Tdap vaccine in the ten years prior to
2018 (Lu et al., 2021). White adults had the highest coverage (36.7%), followed by Black
adults (20.1%), Hispanic adults (20.5%), and Asian adults (25.6%) (Lu et al., 2021).
Between 2010 and 2018, Tdap vaccination coverage increased by 3.2% per year,
increasing from 6.9% in 2010 to 31.2% in 2018 (Lu et al., 2021). While these increases
are encouraging, they are still well below the levels needed to achieve herd immunity
(>95%) necessary to protect vulnerable child and infant populations (Plans-Rubió, 2021).

A separate report on vaccinations in pregnant women reported that Tdap vaccine receipt
during pregnancy in 2019-2020 was 56.6%. Tdap vaccination during pregnancy was
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lowest in Black women (38.8%) and Hispanic women (35.8%). Tdap receipt is highest
among pregnant women in the Midwest (68.8%) and lowest in the South (50.1%)
(Razzaghi et al., 2020).

2.7.6 Attitudes Towards Vaccinations
Attitudes towards immunizations are complex and are influenced by social and cultural
norms, family and peer attitudes, relationship with the medical community, and personal
history of immunization experiences, amongst others (Fiebach & Viscoli, 1991;
Weinstein et al., 2007; Kata, 2010; Yaqub et al., 2014). Understanding attitudes towards
vaccination and particularly about why people are hesitant or resistant to vaccination is
necessary for increasing vaccination coverage, reducing vaccination hesitancy, and
ultimately reducing morbidity and mortality from vaccine-preventable diseases such as
pertussis. Physician or healthcare professional recommendation of a vaccination has been
reported as the most common reason people get vaccinations (Yaqub et al., 2014).
However, fear of negative side-effects and vaccine safety have become barriers to
vaccine acceptance and adherence to vaccination recommendations (Fredrickson et al.,
2004; Kennedy, Basket & Sheedy, 2011; Jana & Osborn, 2013; Yaqub et al., 2014; Saada
et al., 2015; Dubé et al., 2015; Hussain et al., 2018). A critical analysis of attitudes
towards vaccinations reported that safety concerns were the most frequently cited reasons
for hesitancy amongst both the general population as well as healthcare practitioners in
the United Kingdom (Yaqub et al., 2014). While concerns about safety and side effects
are among the most commonly given reasons for vaccine hesitancy, other factors
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including distrust of the medical community (Richmond et al., 2017), governmental
vaccination recommendations (Lee et al., 2016), and a growing interest in treating
diseases with homeopathic methods contribute to hesitancy towards and rejection of
vaccines (Wheelock et al., 2014).

2.7.7 Vaccination Exemptions in the United States
In the United States, state-level policies requiring vaccination of school-going children
have been identified as important strategies for improving vaccination coverage (Omer et
al., 2009). However, vaccination exemptions can be granted for medical, religious, or
philosophical reasons depending on state policy. Currently all states and Washington,
D.C. allow exemptions for medical reasons, 48 states allow religious exemptions, and 20
states allow philosophical or personal belief exemptions (National Conference of State
Legislatures (NCSL), 2021). Increases in vaccination exemptions have been associated
with increased risk of vaccine-preventable diseases like pertussis. Omer et al. (2006)
reported that philosophical/personal belief exemptions were associated with increased
pertussis incidence (Incidence Risk Ratio [IRR])=1.48) between 2000 and 2004 (Omer et
al., 2006). Similarly, Atwell et al.’s geographic analysis of nonmedical exemptions and
pertussis risk in California reported that clusters of non-medical exemptions at the census
tract level were associated with higher pertussis risk (IRR=1.20) (Atwell et al., 2013).
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2.8 Conclusions
Pertussis is a serious disease that has high morbidity and mortality, particularly in infants.
As pertussis is preventable through vaccination, strategies to increase vaccination
coverage are critical to reducing burden of the disease. Research focusing on barriers to
vaccination, including vaccination hesitancy and policies regarding vaccination
exemptions is necessary to develop more effective vaccination strategies. Additionally,
understanding local socioeconomic and demographic risk factors for pertussis are needed
to guide disease control programs.
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CHAPTER 3

ATTITUDES OF EAST TENNESSEE RESIDENTS TOWARD GENERAL AND
PERTUSSIS VACCINATION: A QUALITATIVE STUDY
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3.2 Abstract
Background. Despite vaccination being one of the safest and most successful public
health tools to control infectious diseases, some people still doubt the efficacy and safety
of vaccines. In order to address vaccine hesitancy and anti-vaccination sentiments, it is
necessary to understand vaccination attitude development and vaccination behaviors. The
objective of this project was to qualitatively investigate general vaccination attitudes and
behavior with an additional emphasis on pertussis vaccination.
Methods. To identify factors that influence attitudes toward vaccination and behaviors in
East Tennessee, eleven one-on-one interviews were conducted with participants recruited
through convenience and purposive sampling. Interview protocol and deductive codes
were developed using the Triadic Theory of Influence as a theoretical framework.
Interview transcripts were analyzed qualitatively and themes were identified through
constant comparison of interviews, considering both deductively and inductively coded
data.
Results. Most participants (8) held positive attitudes towards vaccination. Participants (8)
comfortable with vaccinating themselves or their children said they followed
recommendations of doctors. Vaccine hesitant participants’ (3) most frequently cited
concern was safety concerns about side effects. These participants also reported that they
referenced non-academic or professional sources and felt confident about their
knowledge of vaccines and diseases. Vaccine hesitant participants had low perception of
risk of vaccine-preventable diseases, particularly pertussis. Participants with children

36

reported that friends and family were influential when deciding to vaccinate their
children.
Conclusions. This study identified themes in the attitudes towards vaccination of
participants recruited in East Tennessee. We found that risk perception and family and
social group attitudes were the primary influences on vaccination decision making. We
recommend that future studies include anti-vaccination participants and should further
explore the relationship between perception of one’s own knowledge and health
behaviors.

3.3 Background
The United States and Europe are experiencing a return of vaccine-preventable diseases
which has been attributed to anti-vaccine movements (Hotez, 2019). The United States
has experienced multiple measles outbreaks among mostly unvaccinated persons.
Additionally, in 2018, the United States had one of the worst influenza seasons in
decades; it is estimated that 80,000 people died, including many children who were not
vaccinated despite ACIP recommendations (Hotez, 2019).

Vaccines are one of the safest and most successful tools to control and prevent infectious
diseases (SAGE Working Group, 2015). Despite this public health and medical truth
evidenced by extensive empirical literature (Andre et al., 2008), doubt of vaccine efficacy
as well as concerns over side effects by the general public has increased and has resulted
in considerably lower vaccination coverage (SAGE Working Group, 2015). This rise in
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anti-vaccine sentiment has resulted in the World Health Organization (WHO) declaring
vaccine hesitancy, defined as “the reluctance or refusal to vaccinate despite the
availability of vaccines”, as one of the top ten threats to global health in 2019 (World
Health Organization (WHO), 2019). Efforts to understand the contributors to and the
context within people make decisions about vaccinations is necessary for understanding
how to address vaccine hesitancy.

3.3.1 Vaccination Attitudes
Immunization behavior is complicated and difficult to assess. The most commonly cited
reason for receiving vaccines given by those who support vaccination is that they are
recommended by healthcare professionals (Yaqub et al., 2014). However, fear of
vaccine-induced illness and side-effects has become a major barrier to vaccine
acceptance and adherence (Jana & Osborn, 2013; Yaqub et al., 2014; Hussain et al.,
2018). There is evidence that safety is a major concern of parents when deciding to
vaccinate their children (Fredrickson et al., 2004; Kennedy, Basket & Sheedy, 2011;
Saada et al., 2015; Dubé et al., 2015) and has also been identified as the most important
consideration when making vaccine decisions (Fredrickson et al., 2004; Kennedy, Basket
& Sheedy, 2011; Saada et al., 2015) In fact, according to Yaqub and colleagues’ (2014)
critical analysis ‘safety concerns’ were the most frequently cited reason for hesitancy
amongst both the general population as well as healthcare practitioners in the United
Kingdom.
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Recently, public concern regarding adverse outcomes of vaccination such as autism and
Guillain-Barré syndrome has risen (Nowak et al., 2013; Hussain et al., 2018; DeStefano,
Bodenstab & Offit, 2019). Concern regarding autism as an adverse outcome after
vaccination rose after Wakefield et al.’s 1998 study investigating the relationship
between the measles, mumps, and rubella (MMR) vaccine and autism and diarrhea
(Baker, 2008). Despite a complete lack of confirmation by large epidemiologic studies
(Fitzpatrick, 2004) , a retraction of the article on the grounds of research misconduct
(Eggertson, 2010), and the scientific consensus being that there is no causal relationship
between the MMR vaccine and autism, public concern and controversy about the risk for
autism after vaccination has persisted. While concerns about safety and side effects,
particularly those discussed here, are among the most commonly given reasons for
vaccine hesitancy, other factors such as general distrust of the medical community
(Richmond et al., 2017), the government agencies recommending the vaccines (Lee et al.,
2016), a growing interest in homeopathic treatments and obtaining “natural” immunity
through exposure to the disease, contribute to hesitancy towards and rejection of vaccines
(Wheelock et al., 2014).

3.3.2 Attitudes towards pertussis-containing vaccines
The majority of literature regarding vaccine hesitancy focuses on measles, mumps, and
rubella (MMR), human papillomavirus (HPV), and influenza vaccine attitudes.
However, there are only a few empirical publications that address attitudes and barriers to
pertussis vaccination. For example, Miller et al.’s 2011 study investigated the attitudes
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about receipt of the pertussis vaccine shortly after the adult booster was introduced and
found a general willingness of adults to receive the vaccine but a lack of awareness of its
existence or usefulness. Respondents that were not interested in receiving the Tdap
vaccine (55%) gave the following reasons for their decisions: low perceived risk of
getting the disease, fear of needles, a general distrust of vaccines, and that more
information was needed before they could make a decision (Miller et al., 2011). Another
study conducted during a large pertussis outbreak in San Diego found that 66% of the
unvaccinated respondents cited a lack of awareness of the vaccine or that they didn’t
know they needed it (McAuliffe et al., 2011).

Lack of awareness or lack of perception of need has been established as a major barrier to
pertussis vaccine receipt. We do not know, however, what and if other health behavior,
attitudinal, and decision-making factors play a role in people’s decision regarding
pertussis vaccination. Filling this gap is necessary as the incidence of pertussis is
increasing and can cause severe illness in one of our most vulnerable populations—
infants.

3.3.3 Approaches to Understanding Health Behaviors and Vaccine Attitudes
Several models of health behavior have at their foundation the assumption that health
behavior decisions are made rationally (e.g. Health Belief Model, Theory of Reasoned
Behavior). However, we know that people often make health decisions that are not
rational or in their best interest. Behavioral economics asserts that people do not act
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rationally, make decisions based on, amongst other things, inadequate understanding of
possible outcomes, and do not always learn from their mistakes (Rice, 2013). Therefore,
it is necessary to consider psychological and sociological influences when seeking to
understand health behavior. We sought to explore vaccination attitudes using a theoretical
model that does not assume rational decision making in health behavior, specifically the
Theory of Triadic Influence (TTI).

Understanding the social and psychological contexts in which people develop their
vaccination attitudes and make vaccination decisions is necessary to address vaccine
hesitancy (Dubé et al., 2015). The Theory of Triadic Influence (TTI), an integrative,
ecological model, assesses the proximal and distal influences on behavior (Flay et al.,
2009). Extant literature suggests that individual rights (Kata, 2010), previous medical
experiences (Fiebach & Viscoli, 1991), risk assessment (Weinstein et al., 2007), and
family and friends’ attitudes towards vaccination (Yaqub et al., 2014) influence how
people make their vaccine decisions. The TTI includes perceived sense of control,
motivation to comply, others’ behaviors and attitudes, perceived norms, knowledge,
information sources, and institutional interactions as central concepts. We used the TTI as
a framework to investigate how these components related to attitudes and behaviors
regarding vaccination.

Understanding vaccination attitudes is critical to understanding vaccine hesitancy, which
has been identified as a major barrier to vaccination coverage. In fact, a call to action
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regarding further understanding of attitudes towards vaccinations and the barriers
hesitancy and negative attitudes present has been made by global research and public
health communities (Salmon et al., 2015; World Health Organization (WHO), 2019). The
objectives of this project were to qualitatively investigate vaccine attitudes and behavior,
with emphasis on pertussis vaccination. We sought to explore these phenomena by
developing a semi-structured interview protocol based on an integrative, ecological
behavioral model.

3.4 Methods
This project was approved by the University of Tennessee Institutional Review Board
(UTK IRB-15-02724-XP).

3.4.1 Participants and Recruitment
This study involved two samples. The first sample was drawn from the population of the
greater Knoxville, TN area. Participants were recruited using convenience sampling from
community events and through distribution of advertisements around the greater metro
area. Participants were recruited from sixteen community events that occurred between
June 2016 and July 2018. Events included farmer’s markets and multicultural events
from downtown, northern, and western areas of the greater Knoxville area. Flyers were
distributed at these events to recruit people to participate in the study, which led to eleven
interviews, all of which took place in-person at a private location of the participants’
choosing.
42

The second sample was purposely recruited using advertisements in a Facebook group for
people in the Knoxville area that explicitly identified as anti-vaccination. Between June
2016 and July 2018, a total of ten posts were made in this group to recruit participants.
This purposive sampling yielded three responses and zero interviews.

We used snowball sampling with both samples. Participants from both samples and
people who expressed interest in the study were asked to aid in recruiting people they
knew would be interested in participating. We considered that this approach (Luborsky &
Rubinstein, 1995) may increase participant response, particularly from the second, antivaccination sample where trust of researchers is already low and positive word-of-mouth
amongst the community may increase participation. Physical and/or digital copies of the
recruitment flier were offered to all participants or interested persons. Study participation
was voluntary. Each participant was assigned a pseudonym to maintain confidentiality.
No incentives or remuneration were offered to participants.

3.4.2 Procedures
The participants, prior to the beginning of the interview and after obtaining informed
consent, completed a questionnaire developed by the authors for this study to collect
demographic information (Appendix A). Demographic variables included: race, age,
education level, gender, income, and health insurance status (Abdelal et al., 2009; Brady
& Kaplan, 2009).
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The questionnaire asked whether or not the participant has ever received any
vaccinations, if they have children, if they vaccinate their children, and if they had
received a tetanus shot in the last ten years and, if so, what variety it was (e.g. Td (tetanus
and diphtheria), Tdap (tetanus, diphtheria, and acellular pertussis), or unknown).
Semi-structured interviews were conducted with participants (n=11). Semi-structured
interviews followed a pre-determined interview guide, consisting of questions and topics
that would be covered in the interviews but also allow for the interview to cover other
topics if and as they arise (Bernard, 2011). Semi-structured interviews provided
consistency across interviews while also providing flexibility for unanticipated responses
and interviewer follow-up to responses.

Interview topics were developed based on previous literature and theory. Our protocol
included questions about past vaccination experiences, vaccine experiences regarding the
participants’ children (if applicable), comfort level with the medical community,
perceived vaccination attitudes of family and social networks, and the participants’
knowledge of pertussis (Appendix B). Individual values (Kata, 2010), previous medical
experiences (Fiebach & Viscoli, 1991), risk assessment (Weinstein et al., 2007), and
family and friends’ attitudes towards vaccination (Yaqub et al., 2014) are particularly
influential in the development of vaccination attitudes and decisions regarding
vaccination.
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Our interview guide utilized the Theory of Triadic Influence (TTI) as a framework which
includes perceived sense of control, motivation to comply, others’ behaviors and
attitudes, perceived norms, knowledge, information sources, and institutional interactions
as central concepts. Our interview guide was developed to understand the participants’
thoughts about these concepts as they relate to vaccination. For example, the TTI
suggests that others’ attitudes and behaviors influence perceived norms and motivation to
comply. Therefore we explicitly asked our participants about their family and friends’
attitudes towards vaccination. We also asked follow-up questions regarding concerns
expressed by friends or family to understand how participants’ attitudes and behaviors
were received by family and friends. All interviews were conducted in person and were
audio recorded with the consent of the participants. Interviews ranged from 30 to 75
minutes in length. Interviews were transcribed by the first author in word processing
software.

3.4.3 Analysis
Qualitative transcripts were entered into NVivo 12 (QSR International, 2018) for data
management and analysis. Transcripts were read and reviewed multiple times to achieve
immersion. Transcripts were analyzed continuously which allowed for consideration of
saturation defined as no new themes emerging from additional transcripts (Fusch & Ness,
2015). Saturation was used as a guide for sample size following the definition by Given
(2016)-- that additional data do not lead to any new emergent themes (Given, 2016) . We
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knew that saturation had been achieved when, as new data were added, no new themes
emerged but instances of existing codes increased instead (Urquhart, 2013).

A hybrid approach of theory-informed and data-driven deductive and inductive coding
was used when analyzing interview data. For deductive coding, a priori codes were
developed based on the Theory of Triadic Influence as well as extant literature (Fereday
et al., 2006). The first cycle of coding, deductive coding, included nine codes, seven of
which were developed utilizing the Theory of Triadic Influence (Flay, Snyder & Petraitis,
2009) (Table 3.1). These codes were developed to identify anticipated responses based on
the Theory of Triadic Influence as well as by prior literature, including academic and
media publications about vaccination attitudes and behaviors. Theory driven codes were
based on the distal predisposing influences and proximal immediate predictors of the TTI
model and indicated with an asterisk in Table 3.1.

Inductive codes (Table 3.1) were identified throughout the coding process as
unanticipated themes or responses were observed in the transcripts during reading and
coding. Inductive coding was informed by the enumeration of terms and phrases and
constant comparison methods (Boyatzis, 1998). These codes described a new theme or
expanded on a priori deductive codes. A complete list of the codes is presented in Table
3.1.
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Table 3.1 Deductive and Inductive Codes Utilized in Qualitative Analysis
Deductive Codes

Inductive Codes

Theme 1
“Attitudes Toward
Vaccination”
Codes

Comfort with medical community
Concerns about vaccines
Family beliefs*
Social group beliefs*
General attitude toward vaccines*
Risk perception*
Related behaviors*
Knowledge of disease*
Information sources*
Reason for vaccinating children
Reason for not vaccinating children
Confidence in Science
Comfort
Common Sense
Evidence
Too many vaccines
Research
Experience resulted in change
Making own choices/individual freedoms
Trust

General Attitude: Evaluation:
Positive

General Attitude: Evaluation:
Negative
Theme 2:
“Reasons for
Supporting
Vaccination:
Codes

Reason for Vaccinating
Children

Theme 3:
Perceived Risk
“Concerns and
Reasons for Vaccine
Hesitancy” Codes
Perceived Risk of Getting
Pertussis

“I think that [vaccination] is a
good idea”; “I generally think
it is a good thing. It is saving
lives and protecting people,
stopping diseases from being
passed around”
“The flu shot, that’s just a
load of crap”; “I think some
vaccines work”
“Because children used to die
because we had all these
diseases”; “make sure they
don’t get these common
diseases, protect them in the
future”; “everybody gets
“I know the flu shot is
recommended but I have not
caught the flu in a long time”
“now that the kids are older, I
don’t see how we could get
[pertussis]”
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Table 3.2 Continued
Concerns about Vaccines

“Maybe like allergic
reactions”; “I’m more of a
skeptic about what the
government says is safe”;
“The idea that mercury is
one of the preservatives”

Too Many Vaccines

“I think if you pump five
vaccines into your child,
their poor little bodies
can’t deal with it”
“Mostly just our doctors”;
“Our own research”;
“WebMD”

Theme 4:
Knowledge—Information
“Types of Knowledge and Sources
Information Sources”
Codes
*TTI informed codes
*Theory of Triadic Influence
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Four predominant themes emerged from the data: Attitudes Toward Vaccination,
Reasons for Supporting Vaccination, Concerns and Reasons for Vaccine Hesitancy, and
Types of Knowledge and Information Sources. These themes were identified through
constant comparison of interviews, considering both deductively and inductively coded
data.

3.5 Results
3.5.1 Participant Demographic Characteristics
Participant’s demographic characteristics are summarized in Table 3.2. The mean age of
the participants was 34 years and the majority were female (n=6, 55%). Most participants
(n=10, 91%) self-identified as white and non-Hispanic. All participants had completed
high school and most had completed college (n=7, 64%). Most of the study participants
(n=9, 81%) had health insurance and the majority (n=6, 55%) had children.

3.5.2 Theme 1: Attitudes Towards Vaccination
The majority of respondents (n=8, 73%) held positive attitudes regarding vaccination in
general. If participants had had children, they reported that they had their children
vaccinated and up-to-date according to current recommendations. Expressions of support
ranged from vague positivity to clear and thorough sentiment. For example, Aileen said
that they “think [vaccination] is generally a good thing,” and Amelia reported that they
“think vaccinations are a great thing,” and even considered getting vaccinated part of
their civil duty.
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Table 3.3 Demographic Characteristics of Participants (n=11) in Qualitative Study
of Vaccination Attitudes in East Tennessee
Demographic
Characteristic

Mean / Percentage

Age (mean)
Gender

34
Male
Female

45%
55%

White
Black
Hispanic
Asian

91%
0%
9%
0%

Race/Ethnicity

Education
High School or Higher
College or Higher
Graduate
School/Professional
Annual Household Income
<10,000
10,001-25,000
25,001-40,000
40,001-60,000
60,001-75,000
>75,000
Health Insurance
Yes
Private
Public
No
Vaccinated?
Tetanus
Yes
Unsure
Tdap
Yes
Unsure
Has Children
Children Vaccinated
Children have DTaP

100%
82%
64%
9%
18%
9%
27%
27%
0%
81%
45%
36%
9%
100%
82%
18%
27%
73%
55%
100%
100%
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They continued, “I think that in order to keep people healthy that is basically a civil…part
of being a citizen is to have your children vaccinated…”

Three (27%) participants had either mixed or negative feelings about at least some aspect
of vaccination. Vaguely negative sentiments expressed included Fred indicating that they
perceived the necessity of vaccines differently by age group, stating “I think some
vaccines work. Obviously, the ones for the polio, the ones you receive as kids. I think
those work and flu vaccines are needed maybe for children and the elderly but not as a
yearly thing.” Explicitly negative sentiments included participants doubting the efficacy
of some vaccine completely; as Fred said, “The flu shot…that’s just a load of crap.”

3.5.3 Theme 2: Reasons for Supporting Vaccination
The most commonly offered explanation when asked why parents chose to vaccinate
their children was to prevent their children from getting diseases. “Because we don’t
want [them] to get sick,” shared David. Most participants that held positive beliefs about
vaccination also cited historical prevalence of many diseases as a contributing factor to
their consideration of vaccination. Aileen shared that one of their major considerations
when considering vaccination as a general practice was the availability of modern
technology and medicine to prevent diseases,

Because children used to die because we had all of these diseases
that killed off I don’t know how many children in their early years
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and I think it is incredible that we have these things where you can
have one shot and then we don’t have to worry that our kids are
going to die of all these…I mean it makes me want to cry that I don’t
have to worry about it. So I just think it is one of those achievements
of modern medicine that we can eradicate and prevent some really
awful things.

Others shared that they would feel guilty if their child got someone else sick. David
expressed concern that they “wouldn’t want [their child] to be the vector that got one of
[their] immune-suppressed friends sick.”

3.5.4 Theme 3: Concerns and Reasons for Hesitancy
3.5.4.1 Number of Vaccines Administered
Vaccine-hesitant participants cited side effects and the number of vaccines administered at
once as the primary reasons for delaying their children’s vaccination schedule. Aileen said
that they felt like “it’s a lot of stuff to put in [their] tiny body in one visit.” Fred and
Rosemary also expressed the same concern. “Personally, I think if you pump five vaccines
into your child, their poor little bodies can’t deal with it,” Rosemary offered. Fred asked
“How much can your auto-immune system take? Is that something that you should really
be pushing with your children’s health?”
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3.5.4.2 Denial of Efficacy and Safety Concerns
Some participants reported that a major contributor to their refusal or hesitancy to get
vaccines included not trusting vaccine efficacy. “The flu shot…that’s just a load of crap,”
shared Fred. “Like, you’re injecting the flu shot into your body. It’s a virus…you can’t kill
it. So your chances of getting the flu when you take the shot are higher than when you
don’t.” Not only does this reject that the influenza vaccine is effective, it also suggests that
the vaccine causes the very illness it is intended to prevent. Fred was the only participant
to explicitly state that vaccines were ineffective.

3.5.4.3 Concern Regarding Safety, Side Effects, or Negative Consequences of
Vaccination
Most (n=9, 82%) participants expressed minimal concern regarding the safety of vaccines
and stated that while they had safety concerns, they were not significant enough to cause
them to delay or refuse vaccines for themselves or their children. David reported that when
they were getting their first child vaccinated they were concerned that their child would
have an allergic reaction or adverse outcome because of the ingredients. “Oh there’s egg
albumin, does she have any allergies? Then the idea that mercury is one of the
preservatives…,” David recalled from when they had their first child and said that their
concern as normal, explaining “Oh, we’re parents! We worry.”

Some participants had major concerns about side effects and other adverse outcomes.
When discussing vaccines and particularly the influenza vaccine with Rosemary, they
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expressed major concerns about the vaccine’s safety and its impact. “The thing that I worry
about, really, is these diseases mutating and making a comeback…kind of like how the flu
makes a new strand every time they come out with a new vaccine.” Fred added,

I don’t think [influenza vaccines] are healthy for adults. The RNA mutation
is a big concern. And they say that the influenza in the shot is dead but I’m
like ‘yeah but how do you know that?’ That’s what I can’t seem to get an
answer for. A virus can reanimate at any time and you can’t guarantee that.
Other than that, I think the rest of them are safe.

3.5.4.4. Risk Perception of Getting Pertussis
Most participants conceptualized risk of disease differently for their children than they did
for themselves. In fact, many reported that their children were fully vaccinated against
pertussis, but they themselves were not sure if they were up to date. Aileen seemed to
become aware of this incongruence between their behaviors and self-described attitudes
while discussing risk in adult and children. “I feel in some ways that my attitudes are more
pro than my actions,” they said while discussing them not receiving an influenza vaccine
this year while their children did. They went on to say that “maybe I have some kind of
division in my mind between children and adults.”

All participants perceived themselves at very low risk for contracting pertussis. Fred
thought that “now that the kids are older, I don’t see how we could get it.” Rosemary stated,
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“I don’t think we can get it. The doctor says everyone carries it around but from what I’ve
been told, the chances of an adult getting it are slimmer than elderly or an infant so we’re
not worried.” Other notable responses included “I feel like I’ve heard that it affects a lot of
elderly people, maybe? That’s about it,” offered Ted. Nancy thought they didn’t “think
[they] could get it, because [they’ve] had the vaccine.” “I hope,” they continued, “And if I
did get it, it probably wouldn’t be as serious.”

3.5.5 Theme Four: Knowledge and Information Sources
The majority of participants reported speaking with physicians or another healthcare
provider about vaccines when prompted, but otherwise reported either not intentionally
seeking information or seeking it on the internet. Participants that reported never having
sought information themselves reported that they spoke with their doctor when it was
necessary.

Conversations with doctors, pamphlets at physicians’ offices, and internet research were
the most cited sources of information about vaccinations. Elizabeth stated that they talked
to “my doctor and my kids’ doctors. My husband a little bit. And I’ve heard stories on the
news or heard things on the radio, people on TV.” They admitted “Sometimes I google
things about ‘what is this…’ but generally I get more information when I go to the doctor
and they hand you a sheet that has pros and cons and possible reactions…”.
Amelia reported that they consulted their “primary care physician” and got most of their
information at the “the doctor’s office. They give you those pamphlets.” Though the
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same participant also said, “I’ll also go online and look up things…I’ll google and then
go to maybe Mayo Clinic, or someplace I recognize…Cleveland Clinic, CDC, some
place I feel is more credible.”

Participants who perceived their knowledge of pertussis and vaccination as high did not
have high knowledge of these topics and referenced popular science writing as their
primary information sources. Fred and Rosemary cited vague sources like “medical
books from the library” and popular science blogs including “IFL Science” as sources of
information.

Many parents that participated in this study (n = 6, 55%) reported that they did not do
much research about vaccinations or side effects until faced with the idea of vaccinating
their children. Aileen said that they went through “some kind of evolution as far as how I
felt about it because I didn’t do a ton of research before I had kids.”

Outside of physicians and the internet, participants reported discussing vaccinations with
their family and friends and other social entities. Casey even cited “physicians and
coworkers” as the primary two entities with whom they discussed vaccines. David said
they talked with their friends and spouse about vaccines. They reported discussing with
people in their larger social network that planned to not vaccinate their children. The
participant reported that they had conversations about this so that they could try to
understand. Fred reported discussing vaccines with their mother who is “a nurse and she
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even did a little paper about the chemicals in the vaccines and the things that build up in
your system.”

3.6 Discussion
We found that our participants were generally supportive of vaccination, though some
expressed hesitation and concerns. Two participants would be best described as “hesitant
compliers”, people who have major concerns or objections but ultimately decide to comply
with vaccination recommendations. Knowledge about vaccines and disease risk, types of
information sources utilized, and the attitudes of friends and family were important
considerations in our participants’ vaccine behaviors.

3.6.1 Dunning-Kruger, Knowledge, and Vaccine Hesitancy
An important finding in our study was that participants that perceived their knowledge of
pertussis and vaccination as high did not, in fact, have high knowledge of those topics. This
cognitive phenomenon is known as the Dunning-Kruger effect (Dunning, 2011). These
participants were more likely to cite non-academic, non-peer-reviewed, or vague sources
of information when attributing facts. Our participants who demonstrated the most
confidence in their knowledge of pertussis and vaccination and their associated risks were
also the most likely to be incorrect about pertussis risk factors and vaccination side effects.
These participants were also the most vaccine hesitant. Motta and colleagues (2018)
propose that vaccine receipt and vaccination policy ideas are influenced by the DunningKruger effect, a cognitive bias that results from an overconfidence and assessment of their
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own knowledge regarding a subject as higher than it truly is (Dunning, 2011). Fred is an
excellent example of this phenomenon—they offered what they considered factual
knowledge about vaccinations and pertussis with confidence (“The flu makes a new strand
every time they come out with a new vaccine”), referred to the information sources they
utilized and thought them trustworthy (“IFL Science and New Scientist…I try to go with
more credible sources.”), and had major concerns about vaccinating their children (“How
much can your auto-immune system take? Is that something that you should really be
pushing with your children’s health?”). Fred’s overconfidence in their own knowledge of
pertussis, vaccination, and biology is not unusual in vaccine-hesitant or vaccine-refusing
parents (Motta, Callaghan & Sylvester, 2018).

Participants that shared concerns about side effects or consequences of vaccination but who
were not as confident in their knowledge reported following the professional
recommendations of the medical community. David admitted that while they “didn’t know
much about vaccines,” and “were more on the disbelief side and with the belief that there
might be some link to autism,” they ultimately vaccinated their children at their physician’s
recommendation. Vaccinating despite being uncertain about health or other outcomes is
common in vaccine-hesitant parents (Enkel et al., 2018).

Finally, participants that admitted their lack of knowledge regarding pertussis or
vaccination, such as Casey, who at one point in our conversation asked, “is there a
vaccine for pertussis?”, were fully vaccinated and did not express any concerns that
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would prevent them from getting a vaccine. This spectrum of knowledge confidence and
outcomes seen in our participants echoes the hypothesis that overconfidence in one’s own
knowledge about vaccines is consistent with high hesitancy (Motta, Callaghan &
Sylvester, 2018).

3.6.2 Social and Familial Group Influence
Many participants reported that family and friends significantly contributed to their
vaccination beliefs and decisions to get a vaccine for themselves, particularly when
considering vaccinating their children. Rosemary and Fred mentioned that they got their
kids their pertussis vaccine because Fred’s mother “encouraged us to do it” and that
“some friends that had kids said so.” Another participant reported that they had not
considered not vaccinating their child until a family member suggested that they should
not. At that point, the participant reported becoming concerned about vaccines and their
side effects, citing the difficulty of understanding the information about vaccines and
deciding what resources could be trusted. Ultimately, they did decide to vaccine their
children, but the participant reported that it caused a great deal of anxiety. These findings
are consistent with previous literature that suggests that social networks play a significant
role in vaccination decision-making for parents (Brunson, 2013). Acknowledging the
impact that family and friends’ attitudes have on the development of vaccine attitudes
may be useful when developing public health initiatives to address vaccination hesitancy.
Unfortunately, we were unable to recruit any participants who reported being wholly
anti-vaccination despite purposive recruitment efforts. The purposive methodology used
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(posting invitations to participate in an anti-vaccination Facebook group) allowed us to
access a large anti-vaccination group in the study area but no members agreed to
participate. We expect that this is the result of other cultural and ideological factors
shared by this population. It is possible that the anti-vaccination group shares a reluctance
to participate with other hard-to-reach populations (Ozawa et al., 2019). Anti-vaccination
attitudes are not the mainstream ideology and it is possible that people who hold antivaccination beliefs may feel persecuted or unable to safely share their thoughts. Threat of
social consequences, specifically concerns over child protective services being called,
have been expressed in social media posts as a barrier to participation of anti-vaccine
parents.

Our research did not identify any attitudinal barriers to pertussis vaccination specifically.
A lack of awareness of the vaccine was common amongst our participants, with 73% of
participants unsure if they were vaccinated against pertussis or not. Participants that were
aware of their pertussis vaccination status indicated that recent news reports or recently
having a baby as the only reason they knew they were vaccinated. Many participants
perceived their risk of getting pertussis to be low, assumed they were vaccinated as
children and therefore still protected, or assumed that pertussis only made infants sick.
These findings are consistent with reports by Miller et al. (2011) and McAuliffe et al.
(2011).
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3.6.3 Strengths and Limitations
This study has several limitations. We were unable to successfully recruit any explicitly
anti-vaccine persons despite purposive recruitment strategies. As a result, those voices
are not included in our study. Future research should include the perspective of people
who hold anti-vaccination attitudes so that those may be better understood and so that we
can develop and test interventions that would assist in improving vaccination rates for
these groups. Finally, the study sample for this research was small but saturation was
achieved.

Despite this, the authors still feel confident that the major research objective of
understanding important factors of vaccine attitudes was addressed. Additionally, the
theoretical framework that was utilized to create the interview protocol and initial
deductive coding in analysis aided in analyzing interplay of social, cultural and
contextual factors of vaccine attitudes and behaviors. To the best of the authors’
knowledge, this study is the first to utilize the Theory of Triadic Influence to analyze
vaccine attitudes and behavior.

3.7 Conclusions
The results of this study identified themes in the vaccination attitudes of persons in
Knoxville, TN. We found that risk perception and family and social group attitudes were
the primary influences on vaccination decision making, whether for themselves or on
behalf of their children. This is consistent with prior literature that aims at increasing trust
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in and improving access to accurate knowledge about vaccination, increasing educational
campaigns regarding vaccine-preventable diseases, and highlighting the importance of a
physician or medical professional actively addressing vaccine hesitancy in clinical
settings. Our results contribute to the knowledge base utilized by public health officials to
develop and direct immunization health policies and initiatives, as knowledge of local
attitudes and barriers towards vaccination are necessary to guide vaccination coverage
improvement and awareness campaigns. We recommend that future studies include antivaccination participants and should further explore the relationship between perception of
one’s own knowledge and health behaviors.
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CHAPTER 4

GEOGRAPHIC DISPARITIES AND PREDICTORS OF VACCINATION
EXEMPTIONS IN FLORIDA
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4.2 Abstract
Background: In the United States, state-level policies requiring vaccination of schoolgoing children constitute a critical strategy for improving vaccination coverage.
However, policies allowing vaccination exemptions have also been implemented and
contribute to reductions in vaccination coverage and potential increases in the burden of
vaccine-preventable diseases. Understanding the geographic disparities in the distribution
of vaccination exemptions and identifying high risk areas is necessary for guiding
resource allocation and public health control strategies. This study investigated
geographic disparities in vaccination exemptions as well as socioeconomic and
demographic predictors of vaccination exemptions in Florida.
Methods: Vaccination exemption data were obtained from the Florida Department of
Health’s Florida HealthCHARTS web interface. Spatial patterns in geographic
distribution of total and non-medical vaccination exemptions were assessed using countylevel choropleth maps. Negative binomial models were used to identify significant
predictors of county-level risks of both total and non-medical vaccination exemptions.
Results: Total exemptions varied from 0 to 30.2 per 10,000 people. Nine counties had
exemption risks in the top two classes (10.4-15.9 and 15.9-30.2 exemptions per 10,000
people). These counties were distributed in five distinct areas: Western Panhandle,
central northern area, central, South-eastern coastal area, and the southern coastal border
of the state. Non-medical exemptions varied from 0 to 10.4 per 10,000 people. Fifteen
counties had exemption risks in the top two classes (3.7-5.6 and 5.6-10.4 exemptions per
10,000 people), and were located in six distinct areas: Western and Central Panhandle,
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Northeastern, Central-eastern coastal area, Central-western coastal area, and the Southwestern coastal border of the state. Predictors of high risk of total vaccination exemptions
were high density of primary care providers (p<0.001), high median income (p=0.001),
high percentage of Hispanic population (p=0.046), and low percentage of population with
a college education (p=0.013). A predictor of high risk of non-medical vaccination
exemptions was high percentage of White population (p=0.045). However, predictors of
low risks of non-medical exemptions were high percentages of population: living in rural
areas (p=0.023), with college education (p=0.013), with high school education (p=0.009),
and with less than high school education (p<0.001).
Conclusions: There is evidence of county-level geographic disparities in both total and
non-medical vaccination exemption risks in Florida. These disparities are explained by
differences in county-level socioeconomic and demographic factors. Study findings are
important in guiding resource allocation for health planning aimed at improving
vaccination rates and reducing incidence of vaccine-preventable diseases.
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4.2 Introduction
The United States and Europe are experiencing an increase in incidence of vaccinepreventable diseases which has been attributed to anti-vaccine movements (Hotez, 2019).
As a result, the United States has experienced multiple outbreaks of vaccine-preventable
diseases such as measles and pertussis among mostly unvaccinated persons (Sanyaolu et
al., 2019) .The resurgence of vaccine preventable diseases has been, at least partially,
attributed to decreased vaccination coverage.

There is evidence that vaccination coverage varies by geographic region. In the United
States, state-level policies requiring vaccination of school-going children have been
identified as important strategies for improving vaccination coverage (Omer et al, 2009).
On the other hand, policies allowing vaccination exemptions, particularly philosophical
and religious exemptions, have been implicated in contributing to reductions in
vaccination coverage and potential increases in the burden of vaccine-preventable
diseases (Blank, Caplan & Constable, 2013). Unfortunately, vaccination exemption
policies are not consistent across the country and vary widely from state to state.
Currently, all 50 US states and Washington, DC allow medical exemptions for schoolgoing children while 48 states and Washington, DC allow religious exemptions, and 20
allow philosophical or personal belief exemptions (National Conference of State
Legislatures (NCSL), 2021). Across the country, only California, Maine, New York,
Mississippi, and West Virginia do not allow these types of non-medical exemptions
(Constable, Blank & Caplan, 2014; Williams et al., 2019; National Conference of State
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Legislatures (NCSL), 2021). Since states vary widely in the rates of accommodations of
religious or philosophical objections to vaccination (Omer et al., 2006, 2008; Atwell et
al., 2013; Constable, Blank & Caplan, 2014), the ease of getting vaccination exemptions
varies widely. As a result, states having more strict or arduous exemption processes have
lower rates of vaccination exemptions (Omer et al., 2006, 2008; Atwell et al., 2013;
Constable, Blank & Caplan, 2014). The rigor of the approval process for religious
exemptions also varies significantly across the country and often only requires a
parent/guardian’s signature (Blank, Caplan & Constable, 2013).

The role of vaccine exemptions in the transmission of vaccine-preventable diseases,
particularly measles and pertussis, has been of particular interest as incidence rates of
vaccine-preventable diseases have increased. Omer et al. (2006) reported that
philosophical/personal belief exemptions were associated with increased pertussis
incidence (Incidence Risk Ratio [IRR])=1.48) between 2000 and 2004 (Omer et al.,
2006). Similarly, Atwell et al.’s geographic analysis of non-medical exemptions and
pertussis risk in California reported that clusters of non-medical exemptions at the census
tract level were associated with higher pertussis risk (IRR=1.20) (Atwell et al., 2013). An
understanding of the predictors of vaccination exemptions may be useful in guiding
public health policy decisions and efforts geared towards improving vaccination
coverage.
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Non-medical reasons for vaccination exemptions may be closely related to population
socioeconomic and demographic characteristics that, if identified, would guide efforts to
reduce these non-medical exemptions, improve vaccination coverage, and better control
vaccine-preventable diseases. Therefore, the objectives of this study were to identify: (a)
geographic disparities in prevalence of vaccination exemptions; (b) socioeconomic and
demographic predictors of vaccination exemptions among school-going children in
Florida.

4.3 Methods
4.3.1 Study Area
This retrospective study was conducted in Florida, which consists of 67 counties, both
rural and urban (Figure 4.1). Miami-Dade County is the most urban and most populated
with approximately 2.7 million residents while Liberty County is the most rural and least
populated county with approximately 8,300 residents (US Census Bureau, 2018). Florida
population is comprised of 53.2% non-Hispanic White, 26.4% Hispanic, 3% Asian, and
16.9% Black or African American. The remaining 0.5% of the population are Native
Hawaiian or Other Pacific Islander or two or more races (United States Census Bureau).
The population is 51.1% female and 48.9% male and has the following age distribution:
<5 years (5.3%), 6-18 years (19.7%), 19-64 (54.1%), and 65 years and older (20.9%)
(United States Census Bureau).
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Figure 4.1 Geographic distribution of counties and major cities in Florida
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4.3.2 Data Sources and Cartographic Displays
County-level vaccination exemption and population data for 2014 were downloaded from
Florida Health CHARTS (Florida Department of Health, 2020). Cartographic boundary
files, used for creating maps, were obtained from the United States Census Bureau’s
TIGER files (United States Census Bureau, 2019) and the State of Florida Geographic
Data Portal (Southwest Florida Water Management District, 2019). Vaccination
exemptions per 10,000 population at the county level were calculated and displayed in
choropleth maps using ArcGIS (ESRI, 2019). Critical intervals of the choropleth maps
were determined using Jenk’s optimization classification scheme.

4.3.3 Predictors of Total and Non-Medical County-Level Vaccination Exemption
Risks
A conceptual model was used to identify potential county-level predictors of vaccination
exemption risks (Figure 4.2). Based on the conceptual model, a total of 16 potential
predictors were assessed for potential associations with either total and non-medical
vaccination exemption risks (Table 4.1). Predictors of total and non-medical county-level
vaccine exemption risks were investigated using two sets of Poisson models for the two
outcomes, total and non-medical vaccination exemptions. The first step in building the
models involved fitting univariable models between each of the potential predictors and
each of the outcome variables (number of total and non-medical vaccination exemptions)
with population used as the offset (Tables 4.2 and 4.3). Univariable associations were
assessed at a liberal p-value of 0.2 and variables with a p<0.2 were considered for further
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investigation in step two. To minimize potential multicollinearity, two-way Spearman
rank correlation coefficients were computed among variables that had p<0.2. Only one of
a pair of highly correlated variables (i.e., with p>0.7) was retained for assessment in step
2 of the modeling process. The decision on the variable to retain was guided by biological
and statistical considerations (i.e. biological plausibility as well as strength of association
between each of the variables and the outcome). The second step in the modeling process
involved fitting multivariable Poisson model using backwards elimination with the
predictor variables that had p<0.2 in step 1 but this time using a critical p-value of 0.05.
Confounding was assessed by examining whether the removal of a predictor variable
resulted in a >20% change in the coefficients of any other variables in the model (Dohoo,
Martin & Stryhn, 2012). Identified confounders were retained in the models regardless of
their statistical significance. Overdispersion was assessed by comparing model deviance
and degrees of freedom. The Poisson models showed evidence of overdispersion and,
therefore, negative binomial regression models were fit to the data using the same process
outlined above for the Poisson model. All statistical analyses were performed in STATA
version 16.1 (StataCorp, 2019). Overall goodness-of-fit of the final models were assessed
using Deviance and Pearson Chi-square goodness-of-fit tests.
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Figure 4.2 Conceptual model showing sociodemographic variables considered as potential predictors of vaccination
exemptions in Florida, 2014
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Table 4.1 Summary Statistics of potential predictors of vaccination exemptions in Florida, 2014
Variable
Less Than High School Education (%)
High School Education (%)
College Education (%)
White, non-Hispanic (%)
Black, non-Hispanic (%)
Hispanic (%)
Male (%)
Female (%)
Unemployed (%)
Uninsured (%)
Family Below Poverty Line (%)
Individuals Below Poverty Line (%)
Primary Care Providers (per 100,000 pop)
% Living in Rural Area
Rural County (vs Urban)
Scaled Median Income (Divided by $10,000)

Median
14.5
34.3
18.6
83.0
13.1
8.65
49.4
50.6
6.6
18.1
12.8
17.7
48.0
23.8
43063

1st Quartile
11.5
28.9
11.4
77.8
8.6
5.29
48.6
46.7
5.8
15.6
10.1
14.3
28.0
8.5
36907

3rd Quartile
21.7
37.5
26.7
87.6
19.1
18.1
53.3
51.4
7.2
21.1
16.9
22.5
68.0
67.5
48483
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Table 4.2 Results of univariable associations of potential predictors of total vaccination exemptions in Florida, 2014
Variable
Less Than High School Education (%)
High School Education (%)
College Education (%)
White, non-Hispanic (%)
Black, non-Hispanic (%)
Hispanic (%)
Male (%)
Female (%)
Unemployed (%)
Uninsured (%)
Family Below Poverty Line (%)
Individuals Below Poverty Line (%)
Primary Care Providers (per 100,000 pop)
% Living in Rural Area
Rural County (vs Urban)
Scaled Median Income (Divided by $10,000)
1
95% Confidence Interval

Risk Ratio
1.036
0.968
1.012
0.998
1.005
1.014
0.954
1.049
0.958
1.059
1.047
1.024
1.007
0.986
0.523
1.011

Lower 95% CI1
1.032
0.964
1.009
0.997
1.003
1.012
0.941
1.035
0.939
1.056
1.042
1.019
1.006
0.984
0.477
0.983

Upper 95% CI1
1.039
0.972
1.015
1.000
1.007
1.014
0.966
1.062
0.977
1.062
1.052
1.028
1.008
0.987
0.573
1.039

p-value
<0.001
<0.001
<0.001
0.072
<0.001
<0.001
<0.001
<0.001
0.282
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.454
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Table 4.3 Results of univariable associations of potential predictors of non-medical vaccination exemptions in Florida,
2014
Variable
Less Than High School Education (%)
High School Education (%)
College Education (%)
White, non-Hispanic (%)
Black, non-Hispanic (%)
Hispanic (%)
Male (%)
Female (%)
Unemployed (%)
Uninsured (%)
Family Below Poverty Line (%)
Individuals Below Poverty Line (%)
Primary Care Providers (per 100,000 pop)
% Living in Rural Area
Rural County (vs Urban)
Scaled Median Income (Divided by $10,000)
1
95% Confidence Interval

Risk Ratio
0.956
1.010
0.994
1.010
0.986
0.989
1.032
0.969
0.977
0.969
0.938
0.948
0.996
0.999
0.845
1.229

Lower 95% CI1
0.949
1.003
0.990
1.007
0.983
0.988
1.014
0.953
0.945
0.964
0.929
0.939
0.995
0.008
0.745
1.173

Upper 95% CI1
0.963
1.017
0.999
1.013
0.989
0.991
1.049
0.986
1.011
0.976
0.947
0.955
0.998
1.001
0.958
1.285

p-value
<0.001
0.002
0.007
<0.001
<0.001
<0.001
<0.001
<0.001
0.177
<0.001
<0.001
<0.001
<0.001
0.563
0.008
<0.001
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4.3.4 Ethical Statement
This study was reviewed by the University of Tennessee, Knoxville Institutional Review
Board (IRB Number: UTK IRB-20-05957). The board determined that it did not involve
human subjects and, therefore, did not require IRB oversight.

4.4 Results
The largest number of exemptions was in Miami-Dade County (4,157) while the lowest
was in Lafayette county which had no exemptions during the study period. The highest
county-level percentages of exemptions were seen in Seminole (4.8%), Miami-Dade
(2.6%), Columbia (2.6%), Palm Beath (2.4%), Sarasota (2.3%) and St. John’s (2.0%)
counties.

4.4.1 Geographic Patterns of Vaccination Exemptions
Total exemptions varied from 0 to 30.16 per 10,000 persons (Figure 4.3). Nine counties
had exemption risks in the top two classes (10.35-15.85 and 15.86-30.16 exemptions per
10,000 persons) (Figure 4.3). These counties were distributed in five distinct areas of the
state: Western Panhandle (Santa Rosa County), central northern area (Columbia, Union,
and Gilchrist counties, central (Osceola County), South-eastern coastal area (Palm Beach,
Martin, and St. Lucie counties), and the southern coastal border of the state (Miami-Dade
County) (Figure 4.3). Areas with the lowest exemptions (0-3.48 per 10,000 persons) were
primarily seen in the central portion of the state (Hardee, Desoto, Glades, Okeechobee
counties), in the central panhandle (Holmes, Washington, Jackson, Gadsden, Liberty, and
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Gulf counties), and along north-western coastal and northern body of the state (Jefferson,
Taylor, Lafayette, Dixie, Levy, Suwannee, and Hamilton counties). Two other counties in
the northern central part of the state also had low risks of total exemptions (Bradford and
Sumter counties).

Non-medical exemptions varied from 0 to 10.40 per 10,000 persons (Figure 4.3). Fifteen
counties had exemption risks in the top two classes (3.71-5.60 and 5.61-10.40 exemptions
per 10,000 persons) (Figure 4.3). These counties were distributed in six distinct areas of
the state: Western Panhandle (Santa Rosa and Okaloosa Counties), Central Panhandle
(Franklin County), Northeastern (Flagler and Columbia Counties), Central-eastern coastal
area (Indian River, Brevard, Martin, and St. Lucie Counties), Central-western coastal area
(Pinellas, Hernando, and Citrus Counties), and the South-western coastal border of the
state (Monroe, Collier, and Charlotte Counties) (Figure 4.3). Areas with the lowest nonmedical exemptions (0-1.20 per 10,000 persons) were primarily seen in the central
portion of the state (Hardee, Desoto, Hendry, and Okeechobee Counties), in the central
panhandle (Holmes, Washington, Gadsden, Liberty, and Gulf counties), and along the
northern gulf and eastern panhandle area (Jefferson, Taylor, Dixie, Levy, Lafayette,
Suwannee, and Hamilton counties). One other county in the northern central part of the
state also had low medical exemptions (Bradford County).
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Figure 4.3 Total and non-medical vaccination exemptions per 10,000 persons in Florida, 2014
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4.4.2 Predictors of Total Vaccination Exemptions
Since the results of the multivariable Poisson model (Table 4.4) showed evidence of
overdispersion (Deviance/df=29.7; Pearson Chi-square/df=34.02; Likelihood Ratio Test
of overdispersion parameter=0, p<0.001), a negative binomial model was more
appropriate for these data and hence the results of investigation of predictors of total
vaccination exemptions focuses on the negative binomial model results (Table 4.5).
Based on the results of this model, the risk of total vaccination exemptions tended to be
higher in counties with more primary care providers per 10,000 persons, higher median
income, higher percentage of Hispanic population, and higher percentage of population
with a college education than in counties with lower values of these predictors (Table
4.5). There was no evidence of lack of fit of the total exemptions negative binomial
model based on the Deviance goodness-of-fit test (p=0.169) although the Pearson
goodness-of-fit test indicated that the model may not fit the data very well (p=0.048).

4.4.3 Predictors of Non-Medical Vaccination Exemptions
As was the case with the total exemptions model, there was evidence of over-dispersion
(Deviance/df=13.98; Pearson Chi-square/df=16.28; Likelihood Ratio Test of overdispersion parameter=0, p<0.001) of the final Poisson model (Table 4.6) used to
investigate predictors of non-medical exemptions implying that the Poisson model was
not appropriate for the investigation. Therefore, subsequent results presented are based on
the final multivariable negative binomial model (Table 4.7). Based on this model, high
risks of non-medical exemptions tended to occur in counties with higher percentage of
white population. By contrast, lower risks of non-medical exemptions tended to occur in
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counties with higher percentages of the population: (a) living in rural areas, (b) with a
college education, (b) having high school education, and (c) having less than a high
school education. As for the total exemptions model, this model indicated no evidence of
lack of fit based on the Deviance goodness-of-fit test (p=0.153) although the Pearson
goodness-of-fit test indicated that the model did not fit the data well (p=0.003).
4.5 Discussion
This study identified county-level geographic disparities and sociodemographic
predictors of both total and non-medical vaccination exemptions in Florida in 2014.
Study findings provide information that is useful for guiding public health programs and
policy.

4.5.1 Geographic Disparities in Vaccination Exemptions
4.5.1.1 Total Exemptions
The identification of county-level geographic disparities of total vaccination exemptions
in this study is consistent with findings from other studies that investigated geographic
patterns of vaccination exemptions and vaccine-preventable diseases (Omer et al., 2006;
Aloe, Kulldorff & Bloom, 2017). An examination of total vaccination exemptions in
Florida between 2013 and 2019 reported variations of exemptions at the county level
(Muller & Gwynn, 2021). The same study reported that, within Miami-Dade county,
vaccination exemptions varied by school during the 2017-2018 school year (Muller &
Gwynn, 2021). Another study which investigated clustering of vaccination exemptions by
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Table 4.4 Results of the final Poisson model showing significant predictors of total vaccination exemptions in Florida, 2014
Variable
PCP (per 100,000 pop)
Rural (%)
Rural (vs. Urban)
White (%)
Black (%)
Uninsured (%)
Male (%)
Unemployed (%)
Individuals Below Poverty (%)
High School Education (%)
Scaled Median Income (Divided by $10,000)
College Education (%)
1
95% Confidence Interval

Risk Ratio
1.002
0.997
0.421
1.069
1.063
1.039
1.054
0.873
1.0147
0.919
1.101
0.948

Lower 95% CI1
1.000
0.995
0.360
1.053
1.045
1.032
1.029
0.835
1.003
0.901
1.013
0.937

Upper 95% CI1
1.004
0.999
0.493
1.084
1.080
1.047
1.080
0.913
1.027
0.936
1.198
0.960

p-value
0.046
0.041
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.014
<0.001
0.023
<0.001
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Table 4.5 Results of the final negative binomial model showing significant predictors of total vaccination exemptions in
Florida, 2014
Variable
PCP (per 100,000 pop)2
Scaled Median Income (Divided by $10,000)
Hispanic (%)
College Education (%)
1
95% Confidence Interval
2
Primary Care Provide

Risk Ratio

Lower 95% CI1

Upper 95% CI1

p-value

1.017
1.523
1.009
0.962

1.008
1.181
1.00
0.933

1.027
1.964
1.019
0.992

<0.001
0.001
0.046
0.013
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Table 4.6 Results of the final Poisson model showing significant predictors of non-medical vaccination exemptions in
Florida, 2014
Variable
Scaled Median Income (Divided by $10,000)
Rural (%)
Rural (vs. Urban)
White (%)
Black (%)
Hispanic (%)
Male (%)
Families Below Poverty (%)
Individuals Below Poverty (%)
Unemployed (%)
Uninsured (%)
Less than High School (%)
High School Education (%)
College Education (%)
1
95% Confidence Interval

Risk Ratio
1.631
0.993
0.740
1.053
1.050
0.988
1.082
0.904
1.119
1.082
1.082
0.905
0.918
0.897

Lower 95% CI1
1.444
0.989
0.595
1.023
1.019
0.982
1.044
0.861
1.081
1.018
1.062
0.885
0.892
0.879

Upper 95% CI1
1.843
0.996
0.920
1.084
1.083
0.993
1.120
0.949
1.157
0.913
1.027
0.926
0.944
0.916

p-value
<0.001
<0.001
0.007
<0.001
0.002
<0.001
<0.001
<0.001
<0.001
0.012
<0.001
<0.001
<0.001
<0.001
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Table 4.7 Results of the final negative binomial model showing significant predictors of non-medical vaccination
exemptions in Florida, 2014

1

Variable

Risk Ratio

Lower 95% CI1

Upper 95% CI1

p-value

Rural (%)

0 .992

0 .986

0 .999

0.023

White (%)

1.016

1.000

1.032

0.045

College Education (%)

0 .897

0.846

0.951

<0.001

High School Education (%)

0 .898

0 .829

0 .973

0.009

Less than High School (%)

0 .908

0 .874

0 .944

<0.001

95% Confidence Interval
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exemption type (medical, religious, and philosophical) at the school level in Michigan
identified clusters for each exemption type, indicating that geographic differences occur
by type of exemption (Mashinini et al., 2020). Medical exemptions clustered in the
southeast and northwestern regions of the state, religious exemptions were clustered in
the southeastern areas, and philosophical exemptions were clustered in the northeast and
southeastern areas. Another analysis of total vaccination exemptions in Ontario reported
that total vaccination exemptions varied greatly by geographic area (Wilson et al., 2015).
The same study reported that communities with higher vaccination exemption rates
tended to report outbreaks of vaccine-preventable diseases in southwestern Ontario,
including a 2005 rubella outbreak and a 2011 pertussis outbreak (Wilson et al., 2015).
Identifying areas with high exemption rates can not only provide public health
professionals with information to guide resource allocation and programming, but can
also direct surveillance efforts to known areas of increased risk.

4.5.1.2 Non-Medical Exemptions
The geographic disparities in non-medical vaccination exemptions observed at the county
level in this study are consistent with findings from other studies that have reported that
non-medical exemptions are often geographically clustered (Omer et al., 2006). This is a
cause for concern as clustering of unvaccinated or under-vaccinated individuals increases
the risk of outbreaks of vaccine-preventable diseases (Parker et al., 2006). A geospatial
study of non-medical vaccine exemptions and pertussis outbreaks in the United States
reported that geographic clusters of non-medical exemptions were associated with
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pertussis outbreaks in children under five and those aged 10-14 years (Aloe, Kulldorff &
Bloom, 2017). Clusters of non-medical exemptions have also been identified in a schoollevel cluster analysis in Miami-Dade County in the 2017-2018 school year, during which
wide variations between schools were reported (Muller & Gwynn, 2021). The study also
reported that several schools had less than 90% vaccine compliance (Muller & Gwynn,
2021). As with total vaccination exemptions, identification of geographic clusters of nonmedical exemptions can highlight areas for further research, programming, or
surveillance.

4.5.2 Predictors of Vaccination Exemptions
4.5.2.1 Total Exemptions
The observed association between higher median income and total vaccination
exemptions in this study is inconsistent with reports by Quinn et al. from a study of
public attitudes towards vaccination exemptions (Quinn, Jamison & Freimuth, 2020). The
authors reported that adults with an annual income greater than $40,000 favored the idea
of required vaccination and had less favorable attitudes towards exemptions (Quinn,
Jamison & Freimuth, 2020). However, since Quinn et al.’s study reported individuallevel attitudes towards vaccination, direct comparisons cannot be made with the findings
of this county-level study and should be interpreted with caution.

The finding that higher percentage of Hispanic population was a predictor of higher risk
of total exemptions in this study contrasts reports from an Arizona study which reported
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that Hispanic ethnicity was associated with higher vaccination acceptance and coverage
(Birnbaum et al., 2013). Although the observed association between density of primary
care providers and total vaccination exemptions in this study has not been reported
elsewhere, there have been reports of association between density of primary care
providers and non-medical exemptions (Walker & Rea, 2016).

4.5.2.2 Non-Medical Exemptions
The association between white race and higher risk of non-medical vaccination
exemptions observed in this study is consistent with findings from several other studies
that have consistently reported that White race was a predictor of both higher nonmedical exemptions and vaccination hesitancy and refusals (Gust et al., 2005, 2008;
Kennedy, Brown & Gust, 2005; Kennedy et al., 2011; Birnbaum et al., 2013; Richards et
al., 2013; Yang et al., 2016; Morrison, Castro & Meyers, 2020). Yang et al. (2016)
explored the relationship between sociodemographic factors and philosophical
exemptions in California and reported that personal belief exemptions were higher in
areas with higher percentages of white populations (Yang et al., 2016). Similarly, a study
of Arizona school systems reported that schools with higher proportions of white students
had the highest philosophical/personal belief vaccination exemptions (RR=14.11)
(Birnbaum et al., 2013).

Counties with higher percentages of people living in rural areas had lower risk of nonmedical vaccination exemptions, a finding that is consistent with those from a study in
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California which reported lower exemption rates in rural areas (Yang et al., 2016).
However, a longitudinal analysis of community factors associated with non-medical
exemptions in California reported that schools in rural areas had higher non-medical
exemption rates than those in urban areas (Richards et al., 2013). Since that study
investigated exemptions at the census tract level, the differences in findings at different
geographic levels implies that future investigations should consider assessing several
geographic scales including counties, census tracts or school districts.

The finding that higher percentage of the population having a college degree were
associated with lower risk of non-medical vaccination exemptions is consistent with
findings from previous studies. For example, Yang et al. reported that higher education
level was associated with a lower percentage of exemptions at school and regional
geographic levels (Yang et al., 2016). The current study also identified that counties with
higher percentage of the population having high school education and less than high
school education were associated with lower risk of non-medical vaccination exemptions.
These findings highlight the need to investigate the nuances of groups with different
education levels, as they may have attitudinal factors including variations in degrees of
vaccination hesitancy, support of compulsory vaccination policies, and access. For
example, a study by Kennedy and co-workers done at the individual level reported that
persons with at least some college education were more likely to be opposed to
compulsory vaccination (Kennedy, Brown & Gust, 2005). While Kennedy et al.’s study
focused on individual attitudes towards vaccination, it is interesting to see the contrast
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between the individual-level findings of their study compared to the county-level
associations identified here.

Although this study did not identify higher median income as a predictor of higher nonmedical vaccination exemptions, other studies have reported associations between the
two. For instance, McNutt et al. reported that affluence was associated with higher rates
of non-medical exemptions in California (McNutt et al., 2016). Other studies, including
Yang et al.’s analysis of predictors of vaccination exemptions in California, have reported
an association between higher median income and higher percentages of students with
non-medical exemptions (Yang et al., 2016).

Density of primary care providers was a predictor of higher total vaccination exemptions
in this study but was not a significant predictor of non-medical exemptions, which has
been reported in other studies. Walker et al.’s study reported that for every 10% increase
in density of pediatricians there was an 11% decrease in philosophical/personal belief
vaccination exemptions in California (Walker & Rea, 2016). However, they also reported
that a 10% increase in the proportion of family medicine practitioners was associated
with a 3.5% increase in philosophical/personal belief vaccination exemptions (Walker &
Rea, 2016). Future individual-level studies should take these practitioner type differences
into consideration in investigations aimed at improving our understanding of the
socioeconomic and demographic predictors of vaccination exemptions. Finally, the
seemingly counterintuitive observed associations between total/non-medical vaccination
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exemptions and both high levels of education and high median income demonstrates the
complexity of vaccination attitudes and the different streams of influence that impact
them. As mentioned earlier, white race and affluence have been consistently identified as
predictors of vaccination hesitancy and vaccination exemptions. These relationships have
been explored further in ethnographic work that has identified privileged and powerful
identities in society as those that value individual beliefs over guidance offered by
scientific and regulatory or other state entities. For example, a qualitative analysis
examining privilege and personal belief exemptions examined issues of choice as they
relate to concepts of class, gender, and social responsibility (Reich, 2014). The
investigators reported that mothers who refused vaccinations for their children for
philosophical/ideological reasons related their choice to parenting practices. The authors
suggested that members of privileged identities are able to draw upon their access to
resources and privilege to make such choices, like adopting parenting practices based in
natural living and nutritional regimens for disease prevention (Bryden et al., 2019).

4.5.3 Strengths and Limitations
This study has shown evidence of county-level geographic disparities in vaccination
exemptions and that these disparities are influenced, at least in part, by socioeconomic
and demographic factors. However, this study is not without limitations. Exemption data
did not include students in home-school programs and therefore this study could not
account for the home-schooled population. Regardless of this limitation, the findings of
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this study are important for guiding and planning public health programs to reduce
vaccination exemptions and improve health outcomes for vaccine-preventable diseases.
4.6 Conclusions
There is evidence of county-level geographic disparities in both total and non-medical
vaccination exemption risks in Florida. These disparities are explained by differences in
county-level socioeconomic and demographic factors. Study findings are important in
guiding resource allocation for health planning aimed at improving vaccination rates and
reducing incidence of vaccine-preventable diseases.
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CHAPTER 5

GEOGRAPHIC DISPARITIES AND SOCIODEMOGRAPHIC PREDICTORS OF
PERTUSSIS RISK IN FLORIDA
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5.2 Abstract
Background. Pertussis is a toxin-mediated respiratory illness caused by Bordetella
pertussis that can result in severe complications and death, particularly in infants.
Between 2008 and 2011, children less than 3 months old accounted for 83% of the
pertussis deaths in the United States. Understanding the geographic disparities in the
distribution of pertussis risk and identifying high risk geographic areas is necessary for
guiding resource allocation and public health control strategies. Therefore, this study
investigated geographic disparities and temporal changes in pertussis risk in Florida from
2010 to 2018. It also investigated socioeconomic and demographic predictors of the
identified disparities.
Methods. Pertussis data covering the time period 2010–2018 were obtained from Florida
HealthCHARTS web interface. Spatial patterns and temporal changes in geographic
distribution of pertussis risk were assessed using county-level choropleth maps for the
time periods 2010–2012, 2013–2015, 2016–2018 and 2010–2018. Tango’s flexible
spatial scan statistics were used to identify high-risk spatial clusters which were displayed
in maps. Ordinary least squares (OLS) regression was used to identify significant
predictors of county-level risk. Residuals of the OLS model were assessed for model
assumptions including spatial autocorrelation.
Results. County-level pertussis risk varied from 0 to 116.31 cases per 100,000 people
during the study period. A total of 11 significant (p< 0.05) spatial clusters were identified
with risk ratios ranging from 1.5 to 5.8. Geographic distribution remained relatively
consistent over time with areas of high risk persisting in the western panhandle,
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northeastern coast, and along the western coast. Although county level pertussis risks
generally increased from 2010–2012 to 2013–2015, risk tended to be lower during the
2016–2018 time period. Significant predictors of county-level pertussis risk were rurality,
percentage of females, and median income. Counties with high pertussis risk tended to be
rural (p= 0.021), those with high median incomes (p= 0.039), and those with high
percentages of females (p< 0.001).
Conclusion. There is evidence that geographic disparities exist and have persisted over
time in Florida. This study highlights the application and importance of Geographic
Information Systems (GIS) technology and spatial statistical/epidemiological tools in
identifying areas of highest disease risk so as to guide resource allocation to reduce health
disparities and improve health for all.

5.3 Introduction
Pertussis is a toxin-mediated respiratory illness caused by Bordetella pertussis that can
result in severe complications, particularly in infants (<1 year old) (Centers for Disease
Control and Prevention (CDC), 2015). Severe complications include pneumonia and
neurological complications. Between 2008 and 2011, children less than three months old
accounted for 83% of pertussis deaths in the United States. While most of the cases and
especially those that are severe occur in infants, people of all ages are susceptible to the
disease (Clark, 2014) and adolescents and adults are considered the most important
sources of infection for susceptible infants (Centers for Disease Control and Prevention,
2015a; Esposito & Principi, 2016).
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Prior to the development of a vaccine, pertussis was a common disease of childhood and
infancy. Immunization programs initiated in the 1950s dramatically reduced the
incidence of the disease in the United States until the 1980s, when a re-emergence
occurred (Chiappini et al., 2013). While the cause(s) of the re-emergence are still unclear
(Clark, 2014), the severity of disease in infants makes ensuring high vaccination coverage
in all age groups a public health necessity. The rise in cases of the disease among
vaccinated adolescents and school-aged (5–9 years) children (Clark, 2014) has resulted in
concerns that the efficacy and length of the period of immunity provided by the vaccine
may not be as long as initially thought (Jackson & Rohani, 2014; Schwartz et al., 2016;
Esposito et al., 2019). Although vaccines have been well-established as one of the safest
and most successful tools to control and prevent infectious diseases, doubt of vaccine
efficacy as well as concerns over side effects by the general public has increased and has
resulted in decreasing vaccination coverage (Hickler et al., 2015). Research indicates that
variations in vaccination coverage as well as socioeconomic and demographic factors has
contributed to changes in pertussis epidemiology (Omer et al., 2008; Atwell et al., 2013;
Clark, 2014). Race and ethnic disparities in vaccination uptake have also been reported
with minority populations usually having lower vaccination coverage (Williams et al.,
2015). Vaccine hesitancy has been shown to be influenced by demographic,
socioeconomic, and attitudinal factors. For instance, socioeconomic status and level of
education have been identified as major predictors of vaccination acceptance (Blue &
Valley, 2002; Larson et al., 2014). Since pertussis is a vaccine-preventable disease and
demographic and socioeconomic factors influence acceptance and uptake of vaccines, it
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is important to investigate and identify how these factors impact pertussis vaccination and
disease epidemiology.

A number of studies have reported temporal trends in the occurrence of pertussis (Broutin
et al., 2010; Bouchez & Guiso, 2015; Cherry, 2015). Epidemics of the disease have been
reported to occur approximately every 3-5 years across the globe (Broutin et al., 2010;
Clark, 2014; Centers for Disease Control and Prevention, 2015a). This cyclical pattern is
seen in the United States as well (Broutin et al., 2010; Bouchez & Guiso, 2015). Bouchez
and Guiso have suggested that these cycles result from an increase in susceptible hosts
which is influenced by demographic differences and varying vaccine coverage (Bouchez
& Guiso, 2015). They also suggest that temporal changes in disease surveillance may
play an important role in the observed cyclical nature of pertussis epidemics (Bouchez &
Guiso, 2015).

Between 2000 and 2008, the average annual incidence of pertussis in the United States
was 3.4 per 100,000 and between 2009 and 2016, the average incidence rose to 5.9 per
100,000 persons (Skoff, Hadler & Hariri, 2019). An investigation of the geographic
distribution of pertussis in the United States from 2000 to 2016 (Skoff, Hadler & Hariri,
2019) showed that pertussis incidence was highest in the central mid-west (i.e. Kansas,
Nebraska, South Dakota) [11.9 per 100,000 persons] and Rocky Mountain (i.e. Colorado,
Montana, Utah) [11.5 per 100,000 persons] areas. Lowest annual average incidence was
seen in the south Atlantic (i.e. Delaware, Georgia, North Carolina) [2.5 per 100,000
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persons] and southeastern (i.e. Tennessee, Kentucky, Alabama) [3.1 per 100,000 persons]
areas.

The state of Florida has seen a rise in pertussis cases and, as of 2010, it was the only
vaccine-preventable disease with consistent case increases in that state (Schulte et al.,
2010). As of 2019, Florida had a pertussis incidence of 1.85 per 100,000 persons (CDC,
2019). Schulte et al. (2010) reported that the incidence increased from 0.44 to 1.7 per
100,000 persons between 2000 and 2006. (Schulte et al., 2010). This increase in
incidence over time mirrors trends reported across the United States. The authors also
assessed geographic patterns and identified a cluster of ten counties that reported 66% of
the cases seen in the state (Schulte et al., 2010).

Geographic Information System (GIS) technology are increasingly being used in the
investigation and control of chronic and infectious diseases. Geographic and spatial
epidemiologic methods, ranging from data visualization to sophisticated geographically
weighted spatiotemporal models, can be used to understand the degree of geographic
variation in the epidemiology of a disease as well as identify areas and populations at
high risk of illness. The result of this approach can often lead to more targeted, costeffective intervention and prevention efforts. Kauhl et al. (2017), in their analysis of
pertussis testing and incidence in the Netherlands, have suggested that GIS methods and
geographically weighted regression be considered for identifying pertussis outbreaks and
to better direct disease control strategies. Other studies, such as Aloe et al.’s (Aloe,
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Kulldorff & Bloom, 2017) investigation of non-medical vaccination exemptions and
pertussis outbreaks in the United States, demonstrate the utility of exploring
sociopolitical predictors of disease risk, particularly vaccine-preventable disease, as high
rates of exemptions can compromise herd immunity at a small geographic scale that may
otherwise go undetected.

Investigating the spatial epidemiology of pertussis is useful in identifying: (a) geographic
disparities of the disease and (b) determinants of the identified disparities. Moreover,
identification of the predictors of high pertussis risk is important in guiding resource
allocation so as to target control programs to reduce disease risk and improve population
health (Siegal et al., 1997). Therefore, this study investigated geographic disparities and
temporal changes in pertussis risk in Florida from 2010 to 2018. It also investigated and
identified socioeconomic and demographic predictors of the identified geographic
disparities in pertussis risk in Florida.

5.4 Methods
5.4.1 Study Area
This retrospective study investigated pertussis risk in the state of Florida, which consists
of 67 counties, both rural and urban (Figure 5.1). Miami-Dade County is the most urban
and most populated with approximately 2.7 million residents, while Liberty County is the
most rural and least populated county with approximately 8,300 residents (US Census
Bureau, 2018). Florida is 75.4% White, 25% Hispanic, and 16.1% Black or African
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American (US Census Bureau, 2018). The state is 51.1% female and 48.9% male and has
the following age distribution: <5 years (5.4%), 5-9 years (5.5%), 10-14 years (5.7%),
15-19 years (5.8%), 20-24 years (6.2%), 25-34 years (12.9%), 35-44 years (12.1%), 4554 years (13.3%), 55-59 years (6.8%), 60-64 years (6.4%), 65-74 years (10.9%), 75-84
years (6.2%), and ≥85 years and older (2.6%) (US Census Bureau, 2018).

5.4.2 Data Sources and Variable Selection
Yearly number of cases of pertussis for each county for the time period 2010–2018 were
obtained from the Florida Department of Health. Cases were aggregated into three time
periods: 2010–2012, 2013–2015, and 2016–2018. The 3-year aggregation was necessary
due to the very small numbers of yearly cases observed and the fact that pertussis
occurrence has a 3–5 year periodicity (Broutin et al., 2010; Clark, 2014; Bouchez &
Guiso, 2015; Centers for Disease Control and Prevention, 2015b). Population data were
downloaded from Florida Health CHARTS, a community health assessment tool created
by the Florida Department of Health (Florida Department of Health, 2020). Vaccination
exemption data were also obtained from the Florida Department of Health. All
cartographic boundary files used for creating maps were downloaded from the United
States Census Bureau’s TIGER files and the State of Florida Geographic Data Portal
(Southwest Florida Water Management District, 2019). County level age-adjusted
pertussis risks were computed and presented as number of cases per 100,000 persons. A
total of 20 potential predictors of pertussis risk were identified and considered for
investigation at the county level: education, sex,
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Figure 5.1 Geographic distribution of counties and major cities in Florida
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race/ethnicity, income level, employment, health insurance, number of primary care
physicians, percentage of population living in rural areas, vaccination coverage, and
vaccination exemptions (Table 5.1). Variables were initially identified based on literature
as well as biological plausibility of relationships with the outcome.

5.4.3 Investigation of High-Risk Clusters of Pertussis
Tango’s flexible spatial scan statistic (FSSS) was used to identify the geographic
locations of high-risk clusters of pertussis using FleXScan (Tango & Takahashi, 2013).
Since the flexible spatial scanning window detects both circular and irregularly shaped
clusters (Jacquez, 2009; Odoi et al., 2019; Lord, Roberson & Odoi, 2021) it is ideal for
situations like this one involving investigation of clusters whose shapes are unknown at
the outset (Roberson et al., 2019). It has been shown that Tango’s flexible scan statistics
has good power as well as the ability to detect irregularly shaped clusters more accurately
than Kulldorff’s spatial scan statistics (Tango & Takahashi, 2005). Poisson probability
model was used specifying maximum spatial scanning window size of 15 counties.
Clusters were identified based on likelihood ratio tests. For statistical inference, 999
Monte Carlo replications were used, and the null hypothesis of total spatial randomness
was rejected if the p-value was ≤0.05.

5.4.4 Investigation of Predictors of County-Level Pertussis Risk
Predictors of county-level pertussis risk were investigated using an ordinary least squares
regression model.
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Table 5.1 Variables Considered as potential predictors of county-level pertussis risk
in Florida
Variable Theme
Education

Race and Ethnicity
Sex

Economic

Vaccination

Healthcare

Geography

Specific Variable
% Less than High School
% Completed High School
% Completed Bachelor’s Degree
% White, Non-Hispanic
% Black, Non-Hispanic
% Hispanic
% Male
% Female
% Unemployed
% Family Living Below Poverty
% Individual Living Below Poverty
Median Income
% Vaccinated in K-12 Population
% Total Exemptions
% Temporary Medical Exemptions
% Permanent Medical Exemptions
% Religious Exemptions
% Uninsured
Primary Care Physicians per 100,000
population
Rural County (Yes or No)
% Population Living in a Rural Area
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The first step in building the model involved fitting univariable models between each of
the potential predictors and the outcome variable (log-transformed age-adjusted pertussis
risk). Univariable associations were assessed at a liberal p-value of 0.2 and variables with
a p<0.2 were considered for further investigation in step two. Two-way correlations were
run for variables considered for step 2. Only one of a pair of highly correlated variables
(absolute value of r>0.7) were assessed in step two. The decision regarding which of a
pair of highly correlated variables to include in step two was based on biological and
statistical considerations. The second step involved fitting multivariable ordinary least
squares model using manual backwards elimination with the predictor variables identified
for inclusion in step one. During this step statistical significance was assessed using
p≤0.05. Confounding was investigated by assessing whether the removal of a variable
resulted in a >20% change in the coefficients of any other variables in the model (Dohoo,
Martin & Stryhn, 2012). If a confounder was identified, it was forced into the model
regardless of its statistical relationship with the outcome variable. Robust Lagrange
Multiplier (RLM) tests, implemented in GeoDa, were used to assess for spatial
autocorrelation in the residuals using queen spatial weight (Anselin, 2019).
Multicollinearity was assessed using both Variance Inflation Factor (VIF) in SPSS (IBM,
2017) and the Multicollinearity Condition Number in GeoDa (Anselin, Syabri & Kho,
2006).
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5.4.5 Cartographic Displays
All geographic information system (GIS) manipulations and cartographic displays were
performed in ArcGIS (Environmental Systems Research Intitute, 2019). Statistically
significant county-level predictors of pertussis risks, age-adjusted pertussis risks, and
significant clusters of pertussis risk were displayed in maps. The choropleth maps of
pertussis risk and of high-risk clusters were generated for the full study period and threeyear time periods: 2010-2012, 2013-2015, and 2016-2018. Critical intervals in maps of
the determinants of pertussis risk as well as maps of pertussis risk were determined using
Jenk’s optimization classification scheme for the full study period (2010-2018) and were
applied to pertussis risk maps of other time periods for consistency.

5.4.6 Ethical Statement
This study was assessed by the University of Tennessee Institutional Review Board (IRB
Number: UTK IRB-20-05957) which determined that it did not involve human subjects
as defined in 45 CFR 46.102 (e) (1), since it did not involve use of identifiable private
information. Thus, the IRB determined that neither IRB review, nor certification of
exemption from review, was required.

5.5 Results
5.5.1 Geographic and Temporal Distribution of Pertussis Risk
County-level pertussis risk varied from 0 to 116.31 cases per 100,000 persons during the
study period (2010-2018) (Figure 5.2A). Four regions with high risks of pertussis were
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evident: the Pensacola metropolitan area in the western panhandle (Escambia, Santa
Rosa, and Washington counties), the Tampa Bay area (Hillsborough, Pasco, and Polk
counties), Jacksonville metropolitan area (Nassau, Duval, Flagler, Putnam, and St. Johns
counties), and the Cape Coral-Fort Meyers-Naples Area (Collier, Hendry, and Lee
counties) (Figures 5.1 and 5.2A). High risks were also observed in Columbia and
Suwannee counties. Areas of low risk, on the other hand, were evident around Glades,
Union, Liberty, and Calhoun Counties (Figures 5.1 and 5.2A).

The pattern of geographic distribution of pertussis risk was slightly different for the time
period 2010-2012, compared to the whole time period (2010-2018), with high risks being
observed in Santa Rosa county in the western Panhandle, around the northern gulf coast
in Taylor, Lafayette, and Levy counties, in the northwestern region around Jacksonville
in Nassau, Baker, Duval, and Putnam counties, and around the Tampa Bay area in Pasco,
Hillsborough, and Polk counties (Figures 5.1 and 5.2B). Though the general spatial
patterns of pertussis risk for the time period 2013-2015 were similar to those of 20102012, a number of counties (such as Columbia, Suwannee, Washington, etc.) had higher
overall risks in 2013-2015 than 2010-2012 (Figures 5.1 and 5.2B-C). In addition, high
risks were identified in Gilchrist County, around the Tampa Bay area in Pasco,
Hillsborough, Polk, Highlands, DeSoto, Manatee, and Sarasota counties, and around the
Cape Coral area in Lee and Collier counties. Although county level pertussis risks
generally increased from 2010-2012 to 2013-2015, risk tended to be lower during the

107

2016-2018 time period compared to the 2013-2015 period (Figures 5.2C-D). Highest
risks were observed in Nassau County followed by Hillsborough and Hendry counties.

5.5.2 Clusters of High Pertussis Risk
A total of 11 clusters were identified for the analysis that included data for the whole
study period (2010-2018) (Table 5.2 and Figure 5.3A). The primary cluster during this
time period included one county (Hillsborough) and had a risk ratio (RR) of 2.1. The risk
of pertussis in this cluster was 43.1 cases per 100,000 and it had a total of 556 observed
cases of pertussis when only 264 cases were expected. Based on geographic size, the
largest cluster was Cluster 3 which included two counties (Polk and Pasco). The risk of
pertussis in this cluster was 1.51 times higher than the risk outside the cluster. A total of
340 pertussis cases were observed in this cluster when only 223 cases were expected. It
is worth mentioning that the cluster with the highest RR (Cluster 2) included only one
county (Columbia) and had an RR of 5.7, a risk of 116.3 cases per 100,000 persons, 79
observed cases while only 13 were expected. Counties in the Tampa Bay area
(Hillsborough, Polk, and Pasco counties) were consistently included in high-risk clusters
throughout the study period (Figure 5.3A).

Seven clusters, having RRs ranging from 1.6 (in cluster 7) to 3.4 (in cluster 4), were
identified during the time period 2010-2012 (Table 5.3 and Figure 5.3B). The time period
2013-2015, on the other hand, had a total of 11 clusters with RRs ranging from 1.4 (in
cluster 9) to 12.4 (in the primary cluster) (Table 5.4 and Figure 5.3C).
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The latter was located in Columbia County and had the highest RR across all time
periods. Collier county, in the Naples metropolitan area, and Nassau county, in the
greater Jacksonville area, were also identified as parts of high-risk clusters during the
time periods 2013-2015 (Figure 5.3C) and 2016-2018 (Figure 5.3D). The smallest
number of clusters were identified in the 2016-2018 time period (Table 5.5 and Figure
5.3D). This was also the only time period during which a multi-county high pertussis risk
cluster (RR=1.9; p=0.002) was identified.

5.5.3 Predictors of Pertussis Risk
Results of descriptive analysis of the potential predictors and assessment of their
associations with pertussis risk are presented in Table 5.6. The following variables were
assessed in the multivariable model: rural status, education variables, percent female,
primary care providers per 100,000 persons, median income, percent vaccinated, percent
with medical exemption, and percent with religious exemptions. Only three of these
variables were significant in the final model: rurality, county level median income and
percentage of females in the county. County level pertussis risks tended to be high in
rural counties (p=0.021), those with higher median income (p=0.039), and those with
higher percentages of females (p<0.001). It is worth pointing out that % female was a
distorter variable for the association between rurality and risk of pertussis with the
coefficient of the rural variable switching from a negative association with log-risk of
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Figure 5.2 Choropleth Maps Showing Spatial Distribution of Pertussis Risks in Florida, 2010-2018
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Figure 5.3 High Risk Pertussis Clusters in Florida, 2010-2018
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Table 5.2 Significant geographic clusters of pertussis risk in Florida, 2010-2018
Cluster

Population

1
2
3
4
5
6
7
8
9
10
11

1,307,906
67,924
1,106,654
75,569
893,858
656,466
338,270
304,654
160,475
44,263
99,646

Observed
Number of
Cases
556
79
340
51
281
212
127
117
60
22
37

Expected
Number of
Cases
264.45
13.7
223.7
15.2
180.7
132.7
68.3
61.6
32.4
8.9
20.1

Risk per
100,000
people
43.10
116.3
32.28
67.48
31.88
32.44
37.54
38.40
38.01
49.70
37.13

Risk Ratio

p-value

2.10
5.75
1.52
3.34
1.55
1.59
1.86
1.89
1.85
2.46
1.83

0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.01
0.029
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pertussis, in the univariable model, to a positive association in the final model when
percent females is added to the model. There was no evidence of multicollinearity as all
the VIFs were <4 and the multicollinearity condition number was <20 (Table 5.7).
Additionally, there was no evidence of non-normality of the residuals (Jarque-Bera test
p=0.678). Both the Robust Lagrange Multiplier tests for lag (LMlag p=0.585) and error
(LMerror p=0.472) showed no evidence spatial dependence of the residuals.

5.5.4 Geographic Distribution of Significant Predictors of Pertussis Risk
Geographic distributions of the three significant predictors of county-level pertussis risk
are shown in Figure 5.4. Unsurprisingly, the general distribution of these predictors is
similar to the geographic distribution of pertussis risk in Florida between 2010 and 2018
(Figures 5.2 and 5.4A). Santa Rosa and Okaloosa counties in the western panhandle,
Nassau, St. John’s, and Clay counties in the Northwestern coastal area, Hillsborough,
Manatee, and Sarasota counties in the Tampa Bay area, and Collier and Monroe counties
in the Fort Myers area all had relatively high median incomes (Figure 5.4A). These
counties were also consistently identified as counties with high pertussis risk and in high
risk clusters (Figures 5.2 and 5.3)

Counties with higher female population densities are evident in the central panhandle
(Gadsden and Hernando counties) and along the eastern and western coastal borders.
Counties with greater than 52% of the population being female include: Gadsden, Leon,
Sarasota, Hernando, and Pinellas counties (Figures 5.1 and 5.4B). All of these counties
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Table 5.3 Significant geographic clusters of pertussis risk in Florida, 2010-2012

Population

Observed
Number of
Cases

Expected
Number of
Cases

Risk per
100,000 people

Risk Ratio

p-value

1

1,242,491

181

79.69

14.57

2.27

0.001

2

1,072,014

130

68.76

12.14

1.89

0.001

3

1,056,763

123

67.7

10.97

1.81

0.001

4

155,225

34

9.95

21.9

3.41

0.001

5

73,671

16

4.72

21.72

3.38

0.001

6

73,864

16

4.73

21.66

3.37

0.001

7

628,356

65

40.30

10.34

1.61

0.012

Cluster
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Table 5.4 Significant geographic clusters of pertussis risk in Florida, 2013-2015
Cluster

Population

Observed
Number of
Cases

Expected
Number of
Cases

Risk per
100,000 people

Risk Ratio

p-value

1

67,924

77

6.2

113.36

12.4

0.001

2

1,307,906

200

119.5

15.29

1.67

0.001

3

44,263

22

4.04

49.70

5.43

0.001

4

656,466

106

59.9

16.14

1.76

0.001

5

893,858

133

81.6

14.87

1.62

0.001

6

304,654

59

27.8

19.36

2.11

0.001

7

338,270

57

30.9

16.85

1.84

0.002

8

99,646

23

9.1

23.08

2.52

0.005

9

1,106,654

140

101.1

12.68

1.38

0.005

10

24,076

10

2.2

40.01

4.37

0.005

11

388,037

59

35.4

15.20

1.66

0.006
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Table 5.5 Significant geographic clusters of pertussis risk in Florida, 2016-2018
Cluster

Population

Observed
Number of
Cases

Expected
Number of
Cases

Risk per
100,000
people

Risk Ratio

p-value

1

1,388,111

183

68.8

13.18

2.65

0.001

2

79,592

22

3.94

27.64

5.57

0.001

3

961,253

86

47.6

8.94

1.80

0.001

4

507,081

51

25.1

10.05

2.02

0.001

5

474,481

46

23.5

9.47

1.95

0.002

6

312,811

30

15.5

9.59

1.93

0.034
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Table 5.6 Summary statistics and results of univariable analysis of potential predictors of pertussis risk in Florida
Variable

Less Than High School Education
High School Education
College Education
White, non-Hispanic
Black, non-Hispanic
Hispanic
Male
Female
Unemployed
Uninsured
Family Below Poverty Line
Individuals Below Poverty Line
Primary Care Providers (per 100,000)
% Living in Rural Area
Rural County (Yes or No)
Median Income
% K-7th Grade Vaccinated
% K-7th Grade with Vaccination Exemptions
% K-7th Grade with Medical Exemptions
% K-7th Grade with Religious Exemptions

Median

1st
Quartile

3rd
Quartile

14.5
34.3
18.6
83.0
13.1
8.65
49.4
50.6
6.6
18.1
12.8
17.7
48.0
23.8
43063
92.9
7.1
1.7
2.4

11.5
28.9
11.4
77.8
8.6
5.29
48.6
46.7
5.8
15.6
10.1
14.3
28.0
8.5
36907
89.9
4.9
0.8
1.2

21.7
37.5
26.7
87.6
19.1
18.1
53.3
51.4
7.2
21.1
16.9
22.5
68.0
67.5
48483
95.1
10.1
2.3
3.5

Unadjusted
Parameter
Estimate
-0.313
-0.258
0.269
0.094
-0.116
0.040
-0.494
0.494
-0.133
-0.224
-0.164
-0.145
0.305
-0.256
-0.254
0.307
-0.240
0.240
0.138
0.178

Lower
95%
CI
-0.080
-0.090
0.003
-0.016
-0.038
-0.017
-0.184
0.072
-0.334
-0.106
-0.087
-0.075
0.003
-0.015
-0.978
0.095
-0.108
0.000
-0.084
-0.033

Upper p-value
95%
CI
-0.011
0.010
-0.003
0.035
0.056
0.028
0.035
0.449
0.014
0.351
0.023
0.751
-0.072
0.00
0.184
0.00
0.099
0.282
0.004
0.069
0.017
0.184
0.019
0.24
0.021
0.012
-0.001
0.036
-0.028
0.038
0.719
0.011
0.000
0.051
0.108
0.051
0.300
0.265
0.214
0.15
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Table 5.7 Significant predictors of county-level pertussis risk in Florida, 2010-2018

Variables

Exponentiated
Parameter Estimate

Lower CI
(95%)

Upper CI
(95%)

p-value

VIF

Rural (vs. Urban)

1.511

1.134

4.540

0.021

2.82

Scaled Median Income ($10,000)

1.317

1.019

2.031

0.039

1.57

Percent Female

1.982

1.102

1.293

0.000

2.17
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Figure 5.4 Choropleth maps of significant predictors of pertussis risk in Florida, 2010-2018
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have high pertussis risk (>8 per 100,000 persons) and many counties with higher female
populations were identified in high risk clusters, including Hillsborough, Lee, Escambia,
Santa Rosa, Duval, St. John’s, Polk, and Pasco counties. Finally, rural counties, were
predominately located in the central and eastern panhandle and the central body of the
state (Figure 5.1).

5.6 Discussion
This study investigated county-level geographic disparities and temporal changes in, as
well as socioeconomic and demographic predictors of, pertussis risk in Florida from 2010
to 2018. Study findings provide information that is useful for guiding resource allocation
for disease control programs. There is a dearth of research investigating the geospatial
epidemiology of pertussis in the United States and spatial epidemiologic studies of
pertussis predominantly explore the uptake of pertussis vaccines. The information
obtained from this study is useful in understanding of geographic distribution of
pertussis as well as its socioeconomic and demographic predictors. This knowledge is
necessary for guiding public health response, as it helps guide health practitioners to
prioritize areas to target existing public health campaigns as well as develop new
programs to reduce morbidity and mortality. While prevention of pertussis through
education campaigns and vaccination efforts is critical, identifying the sociodemographic
and economic predictors of pertussis risk cannot be overlooked. Therefore, it is necessary
to investigate geographic disparities in risk of the condition and identify socioeconomic
and demographic predictors of any identified geographic disparities in pertussis risk.
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The results of this study indicate that spatial patterns of high pertussis risk exist at the
county level in Florida. This is consistent with findings from other studies that have
reported spatial disparities in pertussis risk in the US (Siegal et al., 1997; Iroh Tam et al.,
2016) and other countries (Kauhl et al., 2017; Mohammadbeigi et al., 2020). A study in
Colorado analyzed data for the time period 1986-1994 and identified consistent clusters
of high pertussis risk in the state (Siegal et al., 1997). The authors reported that high rates
of pertussis were associated with census tracts with higher proportions of residents living
below the poverty line (Siegal et al., 1997). An Iranian study of vaccine-preventable
diseases at the district-level using data for the time period 2015-2018, reported that
pertussis cases were identified in urban areas exclusively (Mohammadbeigi et al., 2020).

Findings from this study indicate that the risk of pertussis was higher during the time
period 2010-2012 than any other time within the study period and a greater number of
counties had higher risks during this time period. This is consistent with an increase in
pertussis risk reported in the United States during this period (Clark, 2014). Temporal
changes and epidemic cycles of pertussis are well documented in the literature (Fine &
Clarkson, 1982; Broutin et al., 2010; Bouchez & Guiso, 2015). Broutin et al.’s
comparative study of 64 countries reported that pertussis epidemics were characterized
by a 3-5 year cyclical pattern. They suggested that these temporal variations were due to
regional variations of demographics, vaccination coverage, surveillance strategies, and
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changes in the circulating bacteria subtypes (Broutin et al., 2010; Bouchez & Guiso,
2015).

The current study also identified high-risk clusters of county-level pertussis risk around
some major metropolitan areas in Florida. These findings are consistent with findings
from other studies, including an analysis of pertussis in Ohio, which reported geographic
clusters of pertussis cases around metropolitan areas (Rowe, 2006). Additionally, a
comparative study of two outbreaks in Minnesota reported an association between
population density and pertussis case density (Wi et al., 2019) which is consistent with
high risk clusters being identified in large metropolitan areas. Similarly, an ecological
analysis of pertussis in Minnesota reported that urban counties had 1.79 times higher risk
of the disease than rural counties (Iroh Tam et al., 2016). Moreover, population density
was also reported as a significant predictive factor, increasing pertussis risk by 6% for
every 100 persons/km2 increase in population density at the public health unit-level in
southern Ontario, Canada (Elghamudi & Berke, 2020). This is expected given that
pertussis is transmitted through respiratory droplets, and hence has high transmissibility
in crowded environments. Given the relatively high reproductive number of 15-17 of
pertussis, it stands to reason that the more densely populated an area is, the more
effective transmission will be (European Centre for Disease Prevention and Control,
2012).
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5.6.1 Predictors of Pertussis Risk
Significant predictors of county-level pertussis risk identified in the current study were
percentage of females, median income, and rurality. Counties with high proportions of
females tended to have high pertussis risk. This is consistent with findings from
individual level studies that reported higher risks of pertussis among females than males
in the United States, Canada, and Poland (De Serres et al., 2000; ParadowskaStankiewicz & Rudowska, 2015). An analysis of an outbreak of pertussis in Quebec,
Canada, reported that the main risk factors for pertussis were being female and working
in an educational or healthcare setting. The authors proposed that the higher risk may be
attributed to greater awareness of pertussis among females which could lead them to seek
medical care more readily than their male counterparts (De Serres et al., 2000). Higher
pertussis risk and pertussis complications among females have also been reported in the
United Kingdom and Canada (Jenkinson, 1995; Abu-Raya et al., 2020). Since the current
study is not an individual-level study, the findings of the above individual-level studies
cannot be directly implied to it. However, it is possible that the associations seen at the
individual-level may apply at the county-level as well. Suffice it to say that this is the
first ecological study that has investigated sex as a potential sociodemographic predictor
of pertussis risk despite evidence at the individual level that sex is an important predictor
of pertussis risk (Broutin et al., 2004; Huang et al., 2017; Alimohamadi et al., 2020).

The association between higher median income and higher county-level pertussis risk
may be related to vaccine refusal since higher median income has been well-documented
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as associated with vaccine refusal for ideological reasons (Wei et al., 2009; Remes et al.,
2014). However, it is worth noting that vaccination delay has also been identified as a
significant contributor to disparities in vaccination coverage and often occurs along
socioeconomic and demographic lines. Children from economically disadvantaged
families, with poor access to healthcare services, often have delays in their vaccination
schedules. This is of particular interest because this delay can increase risk of not only
pertussis illness but other vaccine-preventable diseases as well (Luman et al., 2005;
Feemster et al., 2009; Schaller, Schulkind & Shapiro, 2019). However, children with
vaccine delays are usually fully vaccinated by the time they begin attending school since
it is required unless an exemption has been approved (Schaller, Schulkind & Shapiro,
2019). This may explain why the current study did not identify an association between
vaccination coverage and county-level pertussis risk, since we could not assess the
vaccination coverage of children prior to starting compulsory kindergarten education.

While high-risk clusters were identified around metropolitan areas, the final multivariable
model indicated that risk of pertussis was higher in rural counties than urban counties.
These contradictory findings may be the result of distortion effects of percent females in
the model. However, our finding that rurality is a predictor of higher county-level
pertussis risk is consistent with reports of a geospatial analysis of pertussis in
Saskatchewan, Canada, that rural areas had higher pertussis risk than non-rural areas
(Medu et al., 2018). There is a clear need to explore the relationship between population
density, rurality, and risk of pertussis more deeply, as there is conflict not only in this
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study but also in the literature. Possible explanations for these findings include lower
vaccination rates due to lack of access to healthcare services or geographical differences
related to objections to vaccinations.

5.6.2 Strengths and Limitations
To our knowledge, this is the first study to investigate spatial patterns and clusters of
pertussis in Florida using rigorous spatial epidemiologic methods. The FSSS has several
strengths, over other methods such as the Kulldorff’s spatial scan statistics and local
indicators of spatial associations (LISA) methods such as Moran’s I: (a) it does not have
the problem of multiple comparisons associated with LISA; (b) does not have preselection bias; (c) it is able to detect irregularly shaped clusters since it identifies all
cluster shapes as opposed to Kulldorff’s spatial scan statistics which only identifies
circular or elliptical clusters (Tango & Takahashi, 2005). Moreover, the Tango’s FSSS
has been shown to work better than Kulldorff’s scan statistic for identifying small
clusters (Tango & Takahashi, 2005). County level spatial analysis was necessary to avoid
the small number problem associated with analysis at lower geographical scales because
of the small numbers of cases of pertussis. The identified spatial clusters and predictors
are useful for guiding health planning and policy. In addition to identifying county-level
predictors of pertussis risk, this study has demonstrated the usefulness of using spatial
scan statistic to identify areas where preventive resources are needed through the
identification of high-risk clusters of pertussis. However, this study is not without
limitations. Pertussis is an under-reported disease and, therefore, the county-level
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pertussis risk reported in this study is likely lower than the true risk. Due to the small
number of cases and to protect anonymity and confidentiality of cases, only yearly
pertussis data were used. These data were further aggregated into 3-year time periods for
descriptive investigation to ensure stable estimates due to the small yearly case counts.
Future studies will need to investigate individual level data covering longer study
periods. These limitations notwithstanding, the findings of this study are important for
guiding and planning public health programs.

5.7 Conclusions
There is evidence that geographic disparities exist and have persisted over time in
Florida. This study highlights the importance and application of GIS technology and
spatial statistical/epidemiological tools in identifying areas of highest disease risk so as to
guide targeting of resource allocation to reduce health disparities and improve health for
all.
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CHAPTER 6

SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
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The objectives of this project were to: (a) investigate attitudes towards vaccines and
vaccinations; (b) identify county-level geographic disparities and socioeconomic and
demographic predictors of vaccination exemptions in Florida; and (c) identify geographic
and temporal changes as well as county-level socioeconomic and demographic predictors
of pertussis risk in Florida.

To my knowledge, this study is the first of its kind to utilize the Theory of Triadic
Influence (TTI) to investigate behaviors and attitudes towards vaccines and vaccinations.
This theoretical framework considers the interplay of social, cultural, and contextual
factors of behaviors and attitudes towards vaccines and vaccinations. Risk perception,
safety, and family and social group attitudes were the primary considerations regarding
vaccination decision-making for both individuals, regarding their own vaccinations, and
for parents when considering vaccinating their children. Increasing trust in and improving
access to accurate information about vaccination is critical when making vaccination
decisions. The importance of the role played by physicians and other medical
professionals in actively addressing vaccine hesitancy in clinical settings is also
highlighted by the findings of this study. Knowledge of local attitudes and barriers
towards vaccinations are necessary to guide health education programs aimed at
increasing awareness of the importance of vaccinations and improving vaccination
coverage. Unfortunately, this study covered a predominantly white population with
relatively high education. Therefore, future studies will need to include individuals with
broader racial, educational as well as economic backgrounds. Additionally, better
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understanding of perspectives of individuals who hold explicit anti-vaccination attitudes
should be pursued to gather information that can better guide strategies to improve
vaccination coverage and curb vaccine-preventable diseases. Finally, it is necessary to
bear in mind the political and social contexts of health behaviors, as individuals’
perceptions regarding vaccinations and vaccine preventable diseases may be driven by
their political and social beliefs. Therefore, political ideologies and how they influence
health decisions should be considered. Future studies should consider these issues in both
qualitative and quantitative investigations of attitudes towards vaccinations and their
impact on vaccine preventable diseases.

This study is also the first of its kind to use rigorous spatial epidemiological techniques to
identify geographic disparities of vaccination exemptions in the state of Florida. High
total vaccination exemption risks (greater than 10.35 per 10,000 persons) were observed
in four distinct areas of the state: the western panhandle, north central, central, and
southeastern coast. High non-medical vaccination exemption risks (greater than 3.71 per
10,000 persons) were observed in seven distinct areas of the state: the western and central
panhandle, north central, northeastern coast, central eastern and western coasts, and the
southwestern coast.

High densities of primary care providers, high median income, and high percentages of
Hispanic populations were all associated with high risks of total vaccine exemptions at
the county level while high county-level percentages of population with college
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education were associated with low risks of total vaccine exemptions. On the other hand,
high county-level percentages of white populations were associated with high risks of
non-medical exemptions. By contrast, low risks of non-medical exemptions tended to
occur in counties with higher percentages of the population living in rural areas and in
counties with high percentages of the population with college education, high school
education, and less than a high school education. Knowledge of the geographic
distribution of high total vaccination exemptions can be used to identify areas that are
potentially at high risk of vaccine-preventable diseases. Thus, identifying geographic
disparities of both total and non-medical exemptions can provide valuable insight into
where risks of vaccine-preventable disease may be higher. These findings can be used to
guide disease control initiatives in areas with high exemptions as well as other risk
factors. Future studies should investigate geographic disparities and their predictors at
finer geographic scales to identify how exemptions and risk factors impact disease risk at
the community level for more targeted intervention. Future studies should also consider
further examination of the role that educational level and type of primary care provider
play in vaccination exemption risk.

This study has shown the strength of using spatial scan statistics and Geographic
Information System (GIS) technology for identification of high-risk geographic clusters
of pertussis. The geographic distribution of clusters of high pertussis risk remained
relatively consistent over time, with areas of high risk persisting in the western
panhandle, northeastern coast, and along the western coast. High-risk clusters were also
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consistently identified around some major metropolitan areas of the state. These findings
show evidence of geographic disparities of pertussis risk in Florida and is useful for
guiding resource allocation to control the disease. Future studies should explore not only
pertussis risk at finer geographic levels but should also include other vaccine-preventable
diseases.

Significant predictors of county-level pertussis risk identified in this study included
higher percentage of females, higher median income, and rurality. The association
between high median income and high county-level pertussis risk may be related to
vaccination refusal, as higher median income has been well-documented as associated
with vaccination refusal for ideological reasons. There is a clear need for more detailed
investigations to explore the relationship between population density, rurality, and risk of
pertussis, as there is conflict not only in this study’s findings but also in the literature. It
is possible that these findings reflect lower vaccination rates due to lack of access to
healthcare services or ideological differences regarding vaccinations. Therefore, better
understanding of these issues would be useful for guiding public health interventions.

In conclusion, this project identified important disparities in county-level vaccination
exemptions and pertussis risk as well as important contributors to vaccination hesitancy.
These findings provide useful information for the identification of avenues for further
scientific inquiries on vaccination hesitancy, ways to improve vaccination acceptance and
coverage as well as strategies to reduce burden and disparities in risk of pertussis. This
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project has demonstrated the value of using geographic epidemiologic methods to
identify disparities to guide both public health planning/intervention and future research.
It has also demonstrated that a novel application of theoretical frameworks to investigate
vaccination attitudes is useful for considering the complexities of influences regarding
vaccination hesitancy and vaccination decision-making. Overall, the findings of this
project are important for developing evidence-based public health initiatives, prioritizing
geographic areas, and focusing efforts to reduce the disparities in and burden of vaccinepreventable diseases at the local level.
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Appendix A: Demographic Questionnaire
Date:_______________
Participant Number ________
Age: _____________
Gender (please circle):

Male

Female

Transgender

Another Gender Identity (fill in blank if
desired):__________________
Prefer not to answer
Race/Ethnicity (Circle all that apply):
Black

White (Non--Hispanic)

Hispanic

Other:________________

Education (please circle):
Some High School
High School Degree
Some College
College Degree
Graduate/Professional Degree
Average Annual Income (please circle):
<10,000

10,001--25,000

25,001--40,000

40,001--60,000

60,001--75,000

>75,000
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Do you have health insurance? (please circle):
If yes: Private

Yes

No

Yes

No

Government

Have you ever received a vaccine? (please circle):

If yes, Have you gotten a tetanus shot in the last 10 years? (please circle): Yes
No
If yes, do you know if it included protection against pertussis/whooping
cough (Tdap)? (please circle):
Yes

No

Don’t Know

Do you have children? (please circle):

Yes

If yes, have they ever received a vaccine?

No
Yes

No

If yes, have they received their pertussis/whooping cough (DTaP) series?:
Yes

No
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Appendix B: Interview Questionnaire
I.

Vaccine Attitudes and Knowledge
a. I’d like to hear your thoughts about vaccination in general.
i. What positive things come to mind when you think about vaccination?
ii. What negative things come to mind when you think about vaccination?
b. Who do you talk to about vaccines?
i. What do you talk about when you talk about vaccines?
ii. Who do you feel most comfortable talking to about vaccines?
c. How would you describe your family’s attitudes towards getting vaccines?
i. What do they think about getting vaccines?
ii. What concerns have they expressed about getting any vaccines?
d. How would you describe your friends’ attitudes towards getting vaccines?
i. What do they think about getting vaccines?
ii. Have any of them ever expressed concern that you were getting any
vaccines?
e. Where do you get information about vaccines?

II.

Vaccination Behavior
[Self]
a.

From your survey it looks like that, at some point in your life, you have
received a vaccine. Can you describe one of your experiences when you’ve
received a vaccine?
175

b. Tell me about a time that you have purposefully sought out a vaccine(s). For
example: making an appointment specifically to get one?
i. Prompts and follow ups:
1. What were your reasons for getting that vaccine?
2. What made you decide to schedule the appointment?
3. What, if any, other options did you consider instead of
vaccination?
c. Where do you find it easiest to get your vaccines?
i. What about this place makes it easier for you?
d. Is there anything about getting a vaccine that would you change?
e. What kind of unpleasant experiences have you had getting vaccinated?
i. What caused the unpleasantness?
ii. How have negative experiences like that one influenced your thoughts
about future vaccination?
f. How do you feel about going to the doctor or talking to doctors?
g. How has your doctor impacted your vaccine behavior?
i. Tell me about your thought process when hearing your physicians’
recommendation.

IF “NO” TO HAVING CHILDREN ON QUESTIONNAIRE, SKIP TO III. PERTUSSIS
KNOWLEDGE.
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IF “YES” TO VACCINATING THEIR CHILDREN ON QUESTIONNAIRE:
[Child]
h. You filled in on the questionnaire that you have a child(ren). I’d like to hear
about your experiences getting your child(ren) vaccinated.
i. Why did you get your child(ren) vaccinated?
j. What is it like bringing your child(ren) in to get vaccinated?
i. Where do you find it easiest to get your vaccines?
ii. What part of the process of getting a vaccine would you change?
k. How does the experience of getting your child(ren) vaccinated compare to
getting vaccines for yourself?
i. Did you have any concerns or questions about the vaccine(s) that you
didn’t have when you were getting vaccinated?
IF “NO” TO VACCINATING THEIR CHILDREN ‘ON SCHEDULE’ ON
QUESTIONNAIRE:
[Child]
l. You filled in on the questionnaire that you have a child(ren). I’d like to hear
about your experiences getting your child(ren) vaccinated.
m. What made you decide to not vaccinate/vaccinate on an alternative schedule?

[VACCINATED, BUT OFF SCHEDULE]
n. What is it like bringing your child(ren) in to get vaccinated?
i. Where do you find it easiest to get your vaccines?
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ii. What part of the process of getting a vaccine would you change?
o. How does the experience of getting your child(ren) vaccinated compare to
getting vaccines for yourself?
i. Did you have any concerns or questions about the vaccine(s) that you
didn’t have when you were getting vaccinated?

[NOT VACCINATED]
p. What has been the response from your child’s medical caregivers regarding
your choice not to vaccinate?
i. How do you feel about this feedback?

III.

Knowledge of Pertussis
a. What do you know about whooping cough?
i. Is there anything else that you can think of that you know about this
illness?
b. Sometimes doctors tell us things about specific illnesses. What has your
doctor told you about whooping cough?
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c. Besides your doctor, where else have you heard about whooping cough?
i. Some people tell us that they get information about whooping cough
from the internet, friends, and brochures at the health department. Can
you think of any places where you have heard about whooping cough?
d. Can you tell me about any experience you have had with the disease?
i. I’d like to know more about anyone you know, in your family or
community for example, who has had the disease.
e. How likely do you think it is that you would get whooping cough?
i. What about your children? [if applicable] .

Is there anything else you’d like to share with me about your experiences and ideas about
vaccination or whooping cough?
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